Data / Research funding / Organ Transplantation
Organ Transplantation: 817 NIH awards ($1.1B) to 167 organizations
817 NIH awards ($1.1B) in the NIH spending category Organ Transplantation, to 167 organizations, read 2026-11-03. NIH fiscal years 2021 to 2025.
SpecStream is the live web data engine for teams and agents. It reads the NIH and NSF award files each time the agencies update them, and this page is that reading, joined to the open federal funding opportunities on Grants.gov. Ask for the awards you track by topic, organization or state and new awards arrive in your sheet, CRM, Slack or agent as the agencies publish them.
- Topic
- NIH spending category
Awards
The 500 largest of 817 awards in the window.
| Award | Agency | Institute or division | Fiscal year | Amount in window | Start | End | Principal investigator | Source |
|---|---|---|---|---|---|---|---|---|
| Expanding HOPE Liver Transplantation: Understanding Opportunistic Infection and Cancer Risk | NIH | National Institute of Allergy and Infectious Diseases | 2021 to 2025 | $18,807,472 | August 1, 2018 | August 31, 2030 | DURAND, CHRISTINE MARIE | reporter.nih.gov |
| Assessment of Biomarker Guided CNI Substitution in Kidney Transplantation | NIH | National Institute of Allergy and Infectious Diseases | 2022 to 2025 | $16,391,930 | July 1, 2025 | June 30, 2029 | HEEGER, PETER SCOTT | reporter.nih.gov |
| Targeting Inflammation and Alloimmunity in Lung Transplant Recipients With Clazakizumab | NIH | National Institute of Allergy and Infectious Diseases | 2021 to 2025 | $15,471,597 | September 14, 2021 | June 30, 2028 | MADSEN, JOREN C | reporter.nih.gov |
| Autologous chimeric antigen receptor engineered T cell immunotherapy for desensitization in patients awaiting kidney transplantation | NIH | National Institute of Allergy and Infectious Diseases | 2021 to 2025 | $14,843,451 | August 20, 2021 | May 31, 2028 | NAJI, ALI | reporter.nih.gov |
| Lung Transplant Clinical Trial Network (LT-CTN) | NIH | National Institute of Allergy and Infectious Diseases | 2021 to 2025 | $14,392,000 | June 1, 2025 | May 31, 2028 | PALMER, SCOTT M | reporter.nih.gov |
| A Tolerance Approach to Xenotransplantation | NIH | National Institute of Allergy and Infectious Diseases | 2022 to 2025 | $13,161,555 | September 15, 2000 | December 31, 2026 | SYKES, MEGAN | reporter.nih.gov |
| The Duke Senescent Cell Evaluations in Normal Tissues (SCENT) Mapping Center | NIH | National Institute on Aging | 2021 to 2025 | $12,705,171 | September 30, 2021 | August 31, 2026 | NIXON, ANDREW B. | reporter.nih.gov |
| Human anti-viral immune responses in tissues and circulation | NIH | National Institute of Allergy and Infectious Diseases | 2021 to 2025 | $11,930,741 | January 1, 2017 | February 28, 2027 | FARBER, DONNA L. | reporter.nih.gov |
| Targeting the B Cell Response to Treat Antibody-Mediated Rejection | NIH | National Institute of Allergy and Infectious Diseases | 2021 to 2025 | $11,789,092 | August 20, 2021 | May 31, 2028 | KNECHTLE, STUART JOHNSTON | reporter.nih.gov |
| Advancing Transplantation Outcomes in Children | NIH | National Institute of Allergy and Infectious Diseases | 2021 to 2025 | $11,293,854 | July 1, 2025 | June 30, 2028 | BRISCOE, DAVID M. | reporter.nih.gov |
| Utility of Biomarkers of Rejection and Kidney Injury in Tailoring Liver Transplant Immunosuppression | NIH | National Institute of Allergy and Infectious Diseases | 2021 to 2025 | $10,920,671 | September 6, 2021 | June 30, 2028 | BOIKE, JUSTIN | reporter.nih.gov |
| Cytomegalovirus (CMV) Vaccine in Orthotopic Liver Transplant candidates (COLT) | NIH | National Institute of Allergy and Infectious Diseases | 2021 to 2024 | $9,640,870 | August 26, 2021 | September 30, 2024 | LIMAYE, ABHIJIT PRAKASH | reporter.nih.gov |
| Lung Transplant Consortium - Data Coordinating Center | NIH | National Heart, Lung, and Blood Institute | 2022 to 2025 | $9,634,917 | August 5, 2022 | July 31, 2027 | PALMER, SCOTT M | reporter.nih.gov |
| A trial of transplanting Hepatitis C-viremic kidneys into Hepatitis C-Negative kidney recipients (THINKER-NEXT) | NIH | National Institute of Diabetes and Digestive and Kidney Diseases | 2021 to 2025 | $7,767,541 | April 15, 2021 | March 31, 2027 | SCHAUBEL, DOUGLAS EARL | reporter.nih.gov |
| Strategies to Optimize Pig-to-Primate Kidney Xenograft Survival | NIH | National Institute of Allergy and Infectious Diseases | 2021 to 2025 | $7,360,026 | July 1, 2016 | June 30, 2030 | ADAMS, ANDREW B | reporter.nih.gov |
| Biorepository and Coordinating Center for Studies on Cardiovascular Complications of Human Type 1 Diabetes | NIH | National Institute of Diabetes and Digestive and Kidney Diseases | 2022 to 2025 | $7,099,019 | August 1, 2022 | May 31, 2027 | ATKINSON, MARK A. | reporter.nih.gov |
| Long Term Follow up of the Lung Transplant Outcomes Group Cohort | NIH | National Heart, Lung, and Blood Institute | 2021 to 2025 | $7,078,569 | June 15, 2019 | May 31, 2027 | CHRISTIE, JASON D | reporter.nih.gov |
| Personalized prime editing as a platform for hepatic inborn errors of metabolism | NIH | National Center for Advancing Translational Sciences | 2024 to 2025 | $6,886,793 | September 20, 2024 | August 31, 2028 | AHRENS-NICKLAS, REBECCA CLARE | reporter.nih.gov |
| Subcutaneous Drug Development for Portal Hypertension Ascites | NIH | National Institute of Diabetes and Digestive and Kidney Diseases | 2021 to 2025 | $6,758,500 | September 22, 2014 | July 31, 2027 | CASTILLO, GERARDO M. | reporter.nih.gov |
| The spectrum of cognitive impairment including Alzheimer’s Disease and Related Dementias after liver transplantation | NIH | National Institute on Aging | 2021 to 2025 | $6,330,805 | June 15, 2018 | May 31, 2028 | LAI, JENNIFER C. | reporter.nih.gov |
| Cytomegalovirus (CMV) Vaccine in Orthotopic Liver Transplant candidates (COLT) | NIH | National Institute of Allergy and Infectious Diseases | 2024 to 2025 | $5,882,740 | August 26, 2021 | May 31, 2028 | LIMAYE, ABHIJIT PRAKASH | reporter.nih.gov |
| Kidney Transplantation from Donors with HIV: Impact on Rejection and Long-term Outcomes | NIH | National Institute of Allergy and Infectious Diseases | 2023 to 2025 | $5,224,210 | May 25, 2023 | April 30, 2028 | DURAND, CHRISTINE MARIE | reporter.nih.gov |
| A Randomized Controlled Trial of Prophylaxis with Direct-acting Antivirals for Kidney Transplantation from Hepatitis C virus-infected donor to Uninfected Recipients (PREVENT-HCV) | NIH | National Institute of Allergy and Infectious Diseases | 2022 to 2025 | $5,162,956 | March 25, 2022 | February 28, 2027 | DURAND, CHRISTINE MARIE | reporter.nih.gov |
| Safety and efficacy of Belatacept in heart transplantation | NIH | National Institute of Allergy and Infectious Diseases | 2023 to 2025 | $5,158,955 | June 6, 2023 | March 31, 2028 | HABAL, MARLENA | reporter.nih.gov |
| Comparison of High vs. Standard Dose Influenza Vaccine in Pediatric Solid Organ Transplant Recipients | NIH | National Institute of Allergy and Infectious Diseases | 2023 to 2025 | $5,116,475 | June 9, 2023 | March 31, 2028 | HALASA, NATASHA BASSAM | reporter.nih.gov |
| Composite porcine islet-kidney xenotransplants to cure diabetes and renal failure | NIH | National Institute of Allergy and Infectious Diseases | 2021 to 2024 | $5,035,116 | May 21, 2020 | April 30, 2026 | SACHS, DAVID H | reporter.nih.gov |
| 14/14 APOL1 Long-term Kidney Transplantation Outcomes Network (APOLLO) Scientific Data Research Center | NIH | National Institute of Diabetes and Digestive and Kidney Diseases | 2021 to 2025 | $4,865,046 | September 25, 2017 | May 31, 2028 | FREEDMAN, BARRY IRA | reporter.nih.gov |
| HOPE in Action: A clinical trial of HIV-to-HIV deceased donor kidney transplantation | NIH | National Institute of Allergy and Infectious Diseases | 2021 | $4,782,581 | August 31, 2021 | July 31, 2023 | DURAND, CHRISTINE MARIE | reporter.nih.gov |
| Transplanting Lungs from Uncontrolled Donation after Circulatory Death | NIH | National Heart, Lung, and Blood Institute | 2024 to 2025 | $4,714,267 | July 8, 2022 | June 30, 2027 | WALL, STEPHEN P | reporter.nih.gov |
| Bcl-2 and Mcl-1 inhibition for induction of hematopoietic chimerism and renal allograft tolerance without myelosuppression in nonhuman primates | NIH | National Institute of Allergy and Infectious Diseases | 2022 to 2025 | $4,613,595 | June 3, 2022 | May 31, 2027 | KAWAI, TATSUO | reporter.nih.gov |
| Targeting Inflammation and Alloimmunity in Heart Transplant Recipients with Tocilizumab | NIH | National Institute of Allergy and Infectious Diseases | 2021 to 2023 | $4,466,979 | May 1, 2018 | April 30, 2025 | MADSEN, JOREN C | reporter.nih.gov |
| CD11b: A Novel Alternate Receptor for CD154 during Alloimmunity | NIH | National Institute of Allergy and Infectious Diseases | 2021 to 2025 | $4,188,152 | March 17, 2020 | June 30, 2029 | FORD, MANDY L | reporter.nih.gov |
| A single antiviral to treat multiple opportunistic infections | NIH | National Institute of Allergy and Infectious Diseases | 2021 to 2025 | $3,962,651 | June 15, 2014 | March 31, 2026 | REMISZEWSKI, STACY | reporter.nih.gov |
| Multi-center Evaluation of the Threat of Established and Emerging Respiratory Viral Infections in Pediatric Transplant Recipients | NIH | National Institute of Allergy and Infectious Diseases | 2021 to 2025 | $3,866,357 | September 17, 2021 | August 31, 2027 | STEINBACH, WILLIAM J | reporter.nih.gov |
| Nourexal™: A Novel Bioenergetic Drug to Increase Donor Heart Utilization | NIH | National Heart, Lung, and Blood Institute | 2024 to 2025 | $3,632,845 | September 20, 2024 | June 30, 2026 | ELGEBALY, SALWA A | reporter.nih.gov |
| PERSISTENCE OF IMMUNE RESPONSES TO THE RECOMBINANT ZOSTER VACCINE IN IMMUNE COMPROMISED HOSTS WITH END-STAGE RENAL DISEASE WITH AND WITHOUT KIDNEY TRANSPLANTATION | NIH | National Institute of Allergy and Infectious Diseases | 2021 to 2025 | $3,559,912 | March 6, 2019 | February 28, 2029 | WEINBERG, ADRIANA | reporter.nih.gov |
| Platform for Extended Kidney Preservation Via Subnormothermic Perfusion | NIH | National Institute of Diabetes and Digestive and Kidney Diseases | 2024 to 2025 | $3,527,840 | September 20, 2024 | December 31, 2026 | KOPPARTHY, VARUN LINGAIAH | reporter.nih.gov |
| Role of spleen educated monocytes in mediating ischemia-reperfusion injury followinglung transplant surgery | NIH | National Heart, Lung, and Blood Institute | 2021 to 2025 | $3,525,766 | April 1, 2019 | March 31, 2027 | BHARAT, ANKIT | reporter.nih.gov |
| Specification and Function of Tissue Resident and Recruited Macrophages in Cardiac Remodeling and Heart Failure | NIH | National Heart, Lung, and Blood Institute | 2022 to 2025 | $3,417,341 | January 15, 2022 | December 31, 2028 | LAVINE, KORY J. | reporter.nih.gov |
| Comparison of High Dose vs. Standard Dose Influenza Vaccines in Lung Allograft Recipients | NIH | National Institute of Allergy and Infectious Diseases | 2022 to 2025 | $3,375,497 | February 18, 2022 | January 31, 2027 | HALASA, NATASHA BASSAM | reporter.nih.gov |
| Graft extracellular vesicles as promoters of anti-donor immunity in cardiac and skin transplantation | NIH | National Institute of Allergy and Infectious Diseases | 2022 to 2025 | $3,318,431 | September 19, 2022 | July 31, 2027 | MORELLI, ADRIAN E. | reporter.nih.gov |
| Integrating a culturally competent APOL1 genetic testing program into living donor evaluation | NIH | National Institute of Diabetes and Digestive and Kidney Diseases | 2021 to 2025 | $3,312,983 | April 1, 2021 | March 31, 2027 | AGRAWAL, AKANSHA | reporter.nih.gov |
| Comprehensive Cardiac Structure-Function Analysis in Heart Transplantation | NIH | National Heart, Lung, and Blood Institute | 2021 to 2025 | $3,301,355 | February 4, 2014 | April 30, 2027 | MARKL, MICHAEL | reporter.nih.gov |
| Pathogenesis of lung injury mediated by lung-restricted antibodies | NIH | National Heart, Lung, and Blood Institute | 2021 to 2025 | $3,293,690 | April 1, 2019 | March 31, 2027 | BHARAT, ANKIT | reporter.nih.gov |
| Comparison of High vs. Standard Dose Influenza Vaccines in Adult Solid Organ Transplant Recipients | NIH | National Institute of Allergy and Infectious Diseases | 2021 to 2024 | $3,293,620 | September 1, 2020 | June 30, 2025 | HALASA, NATASHA BASSAM | reporter.nih.gov |
| Targeting innate immunity for induction of robust renal allograft tolerance | NIH | National Institute of Allergy and Infectious Diseases | 2023 to 2025 | $3,224,166 | July 25, 2023 | April 30, 2028 | KAWAI, TATSUO | reporter.nih.gov |
| The Hemodynamic and Metabolic Effects of Advanced Circulatory Support for Resuscitation | NIH | National Heart, Lung, and Blood Institute | 2021 to 2024 | $3,211,098 | March 15, 2021 | February 28, 2026 | HALPERIN, HENRY R | reporter.nih.gov |
| CRISPR-Modified Cardiac Xenograft Transplantation | NIH | National Institute of Allergy and Infectious Diseases | 2021 to 2024 | $3,182,820 | June 10, 2020 | May 31, 2025 | PIERSON, RICHARD N | reporter.nih.gov |
| Intrarenal B cells in acute kidney allograft rejection | NIH | National Institute of Allergy and Infectious Diseases | 2021 to 2024 | $3,165,260 | February 15, 2020 | January 31, 2026 | CHONG, ANITA S | reporter.nih.gov |
| Complement regulates macrophage and platelet function in kidney transplants | NIH | National Institute of Allergy and Infectious Diseases | 2021 to 2025 | $3,127,980 | September 17, 2021 | August 31, 2026 | BALDWIN, WILLIAM M | reporter.nih.gov |
| Targeted immune therapies in heart transplantation | NIH | National Heart, Lung, and Blood Institute | 2023 to 2025 | $3,118,293 | February 1, 2023 | January 31, 2026 | ABDI, REZA | reporter.nih.gov |
| Evaluation of the Mechanisms Underlying Induction and Maintenance Immunosuppression Impact on T Cell Function after Kidney Transplantation | NIH | National Institute of Allergy and Infectious Diseases | 2025 | $3,106,301 | July 16, 2025 | June 30, 2029 | SCHAENMAN, JOANNA M | reporter.nih.gov |
| Epstein Barr Virus Driven Mechanisms of Post Transplant Lymphoproliferative Disease | NIH | National Cancer Institute | 2023 to 2025 | $3,096,663 | September 1, 2023 | August 31, 2028 | MARTINEZ, OLIVIA M | reporter.nih.gov |
| MR-compatible Devices for the Diagnosis and Treatment of Cardiomyopathies | NIH | National Heart, Lung, and Blood Institute | 2021 to 2024 | $3,089,138 | August 20, 2021 | June 30, 2025 | KRAITCHMAN, DARA L | reporter.nih.gov |
| Donor nonclassical monocytes mediate primary graft dysfunction and remote organ injury following lung transplant surgery | NIH | National Heart, Lung, and Blood Institute | 2021 to 2025 | $3,065,003 | January 1, 2019 | December 31, 2028 | BHARAT, ANKIT | reporter.nih.gov |
| NAVIGATE Kidney: A Multi-Level Intervention to Reduce Kidney Health Disparities | NIH | National Institute of Diabetes and Digestive and Kidney Diseases | 2023 to 2025 | $3,050,402 | September 1, 2023 | June 30, 2028 | CERVANTES, LILIA | reporter.nih.gov |
| Acute Antibody Mediated Kidney Allograft Rejection | NIH | National Institute of Allergy and Infectious Diseases | 2021 to 2025 | $3,037,635 | September 17, 2021 | August 31, 2026 | FAIRCHILD, ROBERT L | reporter.nih.gov |
| The novel role of beta3 integrin in regulating alloimmunity | NIH | National Institute of Allergy and Infectious Diseases | 2022 to 2025 | $3,014,928 | February 14, 2022 | January 31, 2027 | ABDI, REZA | reporter.nih.gov |
| Mechanisms of alloantibody production following renal transplantation | NIH | National Institute of Allergy and Infectious Diseases | 2021 to 2025 | $3,014,441 | February 22, 2021 | January 31, 2027 | VALUJSKIKH, ANNA | reporter.nih.gov |
| Predicting the onset of chronic rejection in lung transplant recipients using hyperpolarized 129Xe imaging | NIH | National Heart, Lung, and Blood Institute | 2021 to 2025 | $3,009,446 | June 15, 2020 | May 31, 2026 | RIZI, RAHIM R | reporter.nih.gov |
| Generating Exogenic Organs for Transplantation without the Use of Immunosuppression | NIH | National Institute of Allergy and Infectious Diseases | 2022 to 2025 | $3,005,890 | September 21, 2022 | July 31, 2027 | STEER, CLIFFORD JOHN | reporter.nih.gov |
| Prolonged Normothermic Ex vivo Heart Perfusion (NEVHP) | NIH | National Heart, Lung, and Blood Institute | 2022 to 2025 | $3,004,032 | September 1, 2022 | June 30, 2026 | ROJAS-PENA, ALVARO | reporter.nih.gov |
| BiVACOR - A Physiological, Durable and Blood-Friendly Total Artificial Heart | NIH | National Heart, Lung, and Blood Institute | 2021 to 2023 | $2,992,071 | September 1, 2017 | April 30, 2024 | TIMMS, DANIEL | reporter.nih.gov |
| Integration and functionality of retinal organoid transplants | NIH | National Eye Institute | 2021 to 2025 | $2,971,351 | May 1, 2021 | March 31, 2027 | SEILER, MAGDALENE J | reporter.nih.gov |
| Optimizing Lung Transplant Benefit Using Agent-Based Simulation Modeling Approaches | NIH | National Heart, Lung, and Blood Institute | 2021 to 2025 | $2,960,354 | June 1, 2020 | April 30, 2029 | VALAPOUR, MARYAM | reporter.nih.gov |
| Defining the Landscape of HLA Risk Alleles in Primary Nephrotic Syndrome and Post Kidney Transplant Recurrence | NIH | National Institute of Allergy and Infectious Diseases | 2021 to 2024 | $2,958,614 | June 1, 2020 | May 31, 2026 | GBADEGESIN, RASHEED ADEBAYO | reporter.nih.gov |
| Kidney transplant Preemptive therapy or Prophylaxis (KPoP) for CMVPreventionin D+R- Recipients | NIH | National Institute of Allergy and Infectious Diseases | 2024 to 2025 | $2,952,999 | July 12, 2024 | May 31, 2031 | LIMAYE, ABHIJIT PRAKASH | reporter.nih.gov |
| A critical role for macrophage ferroptosis in promoting fungal invasion in lung transplant recipients | NIH | National Heart, Lung, and Blood Institute | 2021 to 2025 | $2,952,966 | April 1, 2021 | March 31, 2027 | HSU, JOE L | reporter.nih.gov |
| Exosomes and the Immune Response in Allograft Outcomes in Pediatric Transplant Recipients | NIH | National Institute of Allergy and Infectious Diseases | 2021 to 2022 | $2,938,841 | May 10, 2022 | June 30, 2024 | KRAMS, SHERI M. | reporter.nih.gov |
| T-cell depletion and maintenance of the HIV-1 latent reservoir in distinct tissue compartments | NIH | National Institute of Diabetes and Digestive and Kidney Diseases | 2022 to 2025 | $2,927,774 | April 1, 2022 | March 31, 2027 | TOBIAN, AARON A | reporter.nih.gov |
| High subzero preservation of liver for transplantation | NIH | National Institute of Diabetes and Digestive and Kidney Diseases | 2021 to 2025 | $2,898,028 | July 17, 2017 | December 31, 2025 | TONER, MEHMET | reporter.nih.gov |
| Immunogenomic analysis of donor lung injury and its impact on clinical outcomes after lung transplantation | NIH | National Heart, Lung, and Blood Institute | 2022 to 2025 | $2,897,255 | July 10, 2022 | June 30, 2027 | SHAVER, CIARA M | reporter.nih.gov |
| Determinants of T Cell Fate in Transplantation Tolerance | NIH | National Institute of Allergy and Infectious Diseases | 2022 to 2025 | $2,859,856 | August 1, 2022 | July 31, 2027 | FORD, MANDY L | reporter.nih.gov |
| Early-Stage Preclinical Validation of Carbon Monoxide Prodrugs for Acute Kidney Injury | NIH | National Institute of Diabetes and Digestive and Kidney Diseases | 2022 to 2025 | $2,842,625 | July 15, 2022 | June 30, 2027 | WANG, BINGHE | reporter.nih.gov |
| Characterization of Renal Allograft Fibrosis and Prediction of Outcome Using a Quantitative MRI Approach | NIH | National Institute of Diabetes and Digestive and Kidney Diseases | 2021 to 2025 | $2,812,749 | July 8, 2021 | April 30, 2027 | LEWIS, SARA C | reporter.nih.gov |
| Improving Medication Adherence in adolescents who had a Liver Transplant: iMALT | NIH | National Institute of Diabetes and Digestive and Kidney Diseases | 2021 to 2023 | $2,801,000 | September 20, 2018 | August 31, 2025 | SHEMESH, EYAL | reporter.nih.gov |
| Cognitive Function, Self-Management, and Health Outcomes among Liver Transplant Recipients: the LivCog Cohort | NIH | National Institute of Diabetes and Digestive and Kidney Diseases | 2022 to 2025 | $2,788,955 | May 4, 2022 | February 28, 2027 | SERPER, MARINA | reporter.nih.gov |
| Reaching Equity in ACess to Home Dialysis And Re-Transplantation (REACH-DART) | NIH | National Institute of Diabetes and Digestive and Kidney Diseases | 2022 to 2025 | $2,785,676 | May 15, 2022 | February 28, 2027 | KU, ELAINE | reporter.nih.gov |
| Novel Biomarkers for Post-Liver Transplant NASH Fibrosis | NIH | National Institute of Diabetes and Digestive and Kidney Diseases | 2022 to 2025 | $2,777,764 | July 18, 2022 | May 31, 2027 | ARTEEL, GAVIN E | reporter.nih.gov |
| Technology Enabled Strategies to Promote Treatment Adherence in Liver Transplant: The TEST Trial | NIH | National Institute of Diabetes and Digestive and Kidney Diseases | 2022 to 2025 | $2,750,911 | May 19, 2022 | April 30, 2027 | SERPER, MARINA | reporter.nih.gov |
| Role of TRPV4 channel signaling in lung ischemia-reperfusion injury | NIH | National Heart, Lung, and Blood Institute | 2021 to 2024 | $2,714,601 | April 15, 2021 | March 31, 2026 | LAUBACH, VICTOR E | reporter.nih.gov |
| INSPIRE: INterventionS for Promoting kIdney tRansplant Empowerment | NIH | National Institute of Diabetes and Digestive and Kidney Diseases | 2023 to 2025 | $2,713,953 | September 1, 2023 | June 30, 2028 | CHAN, LILI | reporter.nih.gov |
| Predictive modeling of acute rejection in pediatric heart transplant recipients | NIH | National Heart, Lung, and Blood Institute | 2022 to 2025 | $2,708,586 | July 15, 2022 | June 30, 2027 | SOSLOW, JONATHAN HARVEY | reporter.nih.gov |
| Metagenomic profiling of urinary cell-free DNA to monitor urinary tract infection after kidney transplantation | NIH | National Institute of Allergy and Infectious Diseases | 2021 to 2024 | $2,705,917 | March 10, 2020 | February 28, 2026 | DE VLAMINCK, IWIJN | reporter.nih.gov |
| The role of HLA and its coreceptors in endothelial cell activation and leukocyte recruitment in antibody-mediated transplant rejection | NIH | National Institute of Allergy and Infectious Diseases | 2021 to 2025 | $2,702,674 | September 1, 2018 | January 31, 2029 | REED, ELAINE F | reporter.nih.gov |
| Effect of Alkali Therapy on Vascular and Graft Function in Kidney Transplant Recipients | NIH | National Institute of Diabetes and Digestive and Kidney Diseases | 2021 to 2025 | $2,690,675 | June 18, 2021 | April 30, 2027 | KENDRICK, JESSICA B | reporter.nih.gov |
| Peptide-dependent mobilization of CD8 regulatory cells in cardiac transplantation | NIH | National Institute of Allergy and Infectious Diseases | 2023 to 2025 | $2,660,122 | August 21, 2023 | July 31, 2027 | AZZI, JAMIL | reporter.nih.gov |
| Post-transcriptional regulation of gene expression by microRNAs in antibody-mediated rejection | NIH | National Institute of Diabetes and Digestive and Kidney Diseases | 2022 to 2025 | $2,653,376 | September 1, 2022 | July 31, 2027 | IACOMINI, JOHN J | reporter.nih.gov |
| Airway epithelial cell and lymphocyte interactions in chronic lung allograft dysfunction pathogenesis | NIH | National Heart, Lung, and Blood Institute | 2022 to 2025 | $2,652,554 | August 15, 2022 | July 31, 2027 | GREENLAND, JOHN | reporter.nih.gov |
| Objective lung assessment tools for improved organ use in lung transplantation | NIH | National Heart, Lung, and Blood Institute | 2021 to 2025 | $2,625,302 | July 15, 2021 | August 31, 2025 | CANTU, EDWARD | reporter.nih.gov |
| Impact of Randomized Payment Incentives on Disparities in Home Dialysis and Kidney Transplantation | NIH | National Institute on Minority Health and Health Disparities | 2022 to 2025 | $2,608,764 | February 9, 2022 | November 30, 2026 | TRIVEDI, AMAL N. | reporter.nih.gov |
| Chronic Antibody-Mediated Rejection of Kidney Allografts | NIH | National Institute of Allergy and Infectious Diseases | 2022 to 2025 | $2,566,057 | February 1, 2022 | January 31, 2027 | FAIRCHILD, ROBERT L | reporter.nih.gov |
| Increasing Live Donor Kidney Transplantation Through Video-based Education and Mobile Communication | NIH | National Institute of Diabetes and Digestive and Kidney Diseases | 2021 to 2024 | $2,560,634 | August 15, 2021 | July 31, 2025 | KAYLER, LIISE | reporter.nih.gov |
| Renal Anhydramnios Fetal Therapy (RAFT) Trial | NIH | Eunice Kennedy Shriver National Institute of Child Health & Human Development | 2021 to 2024 | $2,540,189 | April 1, 2020 | February 28, 2026 | ATKINSON, MEREDITH ANN | reporter.nih.gov |
| Modeling, pathogenesis and treatment of idiopathic pulmonary fibrosis | NIH | National Heart, Lung, and Blood Institute | 2021 to 2022 | $2,527,128 | September 20, 2016 | May 31, 2025 | SNOECK, HANS-WILLEM E | reporter.nih.gov |
| Promoting Increases in Living Organ Donation via Tele-navigation (PILOT) | NIH | National Institute of Diabetes and Digestive and Kidney Diseases | 2021 to 2024 | $2,523,913 | April 1, 2021 | February 28, 2026 | LOCKE, JAYME ELIZABETH | reporter.nih.gov |
| Automatic Wide-Field Optical Coherence Tomography for Assessment of Transplant Kidney Viability | NIH | National Institute of Diabetes and Digestive and Kidney Diseases | 2022 to 2025 | $2,502,656 | September 15, 2022 | July 31, 2027 | ZHANG, XIAOHUI FRANK | reporter.nih.gov |
| Organ banking for transplant--kidney cryopreservation by vitrification and novel nanowarming technology | NIH | National Institute of Diabetes and Digestive and Kidney Diseases | 2021 to 2025 | $2,474,268 | April 13, 2018 | March 31, 2027 | FINGER, ERIK BRIAN | reporter.nih.gov |
| Genetic-engineered control of the immunogeneic state of vascular composite allografts during preservation | NIH | National Institute of Biomedical Imaging and Bioengineering | 2021 to 2025 | $2,471,566 | July 1, 2021 | March 31, 2029 | UYGUN, KORKUT | reporter.nih.gov |
| Characterizing Emerging Humanized Immune Mouse Models for the study of transplant rejection and infectious disease pathology (Epstein Barr Virus) | NIH | National Institute of Allergy and Infectious Diseases | 2021 to 2023 | $2,464,113 | February 2, 2021 | August 30, 2024 | BROWN, MATTHEW E | reporter.nih.gov |
| Preservation of DCD Allograft Integrity for Liver Transplantation | NIH | National Institute of Diabetes and Digestive and Kidney Diseases | 2021 to 2024 | $2,457,892 | January 13, 2020 | November 30, 2025 | BLACK, SYLVESTER M | reporter.nih.gov |
| Pathogenesis of Airway Stem Cell Abnormalities in Obliterative Bronchiolitis | NIH | National Heart, Lung, and Blood Institute | 2021 to 2025 | $2,452,366 | April 1, 2019 | January 31, 2029 | PAREKH, KALPAJ RAJNIKANT | reporter.nih.gov |
| Improving Access to Nephrology Treatment and Care among Patients at Greatest Risk for Kidney Failure | NIH | National Institute of Diabetes and Digestive and Kidney Diseases | 2023 to 2025 | $2,442,134 | September 1, 2023 | June 30, 2028 | ARRIOLA, KIMBERLY RUTH JACOB | reporter.nih.gov |
| Tomotherapy and Hematopoietic Stem Cells for Tolerance to Kidney Transplants | NIH | National Institute of Allergy and Infectious Diseases | 2021 to 2022 | $2,439,463 | August 1, 2012 | April 30, 2024 | KAUFMAN, DIXON B | reporter.nih.gov |
| Post-Transplant Inflammatory Response | NIH | National Institute of Allergy and Infectious Diseases | 2021 to 2025 | $2,437,884 | April 1, 1997 | November 30, 2029 | FAIRCHILD, ROBERT L | reporter.nih.gov |
| Immunoregulatory Mechanisms of IL-33 in Heart Transplantation | NIH | National Heart, Lung, and Blood Institute | 2022 to 2025 | $2,429,537 | August 10, 2022 | June 30, 2027 | TURNQUIST, HETH R | reporter.nih.gov |
| New approaches to kidney banking through nature-inspired high sub-zero preservation strategies | NIH | National Institute of Diabetes and Digestive and Kidney Diseases | 2023 to 2025 | $2,410,750 | August 5, 2019 | August 31, 2026 | WEEGMAN, BRADLEY P | reporter.nih.gov |
| Designing induction therapies to target memory T cells in high risk recipients | NIH | National Institute of Allergy and Infectious Diseases | 2021 to 2025 | $2,405,990 | July 15, 2014 | August 31, 2027 | VALUJSKIKH, ANNA | reporter.nih.gov |
| The immunogenicity and pathogenicity of HLA-DQ in solid organ transplantation | NIH | National Institute of Allergy and Infectious Diseases | 2023 to 2025 | $2,399,982 | August 17, 2023 | July 31, 2027 | TAMBUR, ANAT R. | reporter.nih.gov |
| Targeting heat shock protein 72 to improve renal function after transplantation | NIH | National Institute of Diabetes and Digestive and Kidney Diseases | 2021 to 2025 | $2,394,886 | March 15, 2021 | July 31, 2026 | PARAJULI, NIRMALA | reporter.nih.gov |
| Development of heparan sulfate-based therapeutics to treat inflammatory diseases | NIH | National Institute of General Medical Sciences | 2023 to 2025 | $2,387,583 | September 14, 2021 | July 31, 2026 | WANG, ZHANGJIE | reporter.nih.gov |
| Virtually Supervised Exercise for Kidney Transplant Candidates | NIH | National Institute of Diabetes and Digestive and Kidney Diseases | 2022 to 2025 | $2,386,134 | September 15, 2022 | August 31, 2027 | LIU, CHRISTINE KEE | reporter.nih.gov |
| Access to Kidney Transplantation in Minority Populations (AKT-MP) | NIH | National Institute on Minority Health and Health Disparities | 2021 to 2025 | $2,384,015 | July 7, 2020 | January 31, 2026 | MYASKOVSKY, LARISSA | reporter.nih.gov |
| Overcoming humoral rejection after xenotransplantation in sensitized nonhuman primate recipients | NIH | National Institute of Allergy and Infectious Diseases | 2023 to 2025 | $2,378,023 | February 6, 2023 | January 31, 2028 | KWUN, JEAN | reporter.nih.gov |
| In Vivo Detection And Mechanisms of Regulatory B cell Function in Transplantation | NIH | National Institute of Allergy and Infectious Diseases | 2021 to 2025 | $2,357,214 | July 1, 2015 | March 31, 2027 | ROTHSTEIN, DAVID M | reporter.nih.gov |
| Immunosuppression-free transplantation through placental mimicry | NIH | National Institute of Allergy and Infectious Diseases | 2021 to 2024 | $2,355,000 | September 14, 2021 | August 31, 2026 | WEAVER, JESSICA DIANE | reporter.nih.gov |
| Outcomes in living kidney donors over 50 years compared to a healthy matched contemporaneous non-donor cohort from the same geographical region | NIH | National Institute of Diabetes and Digestive and Kidney Diseases | 2021 to 2024 | $2,341,803 | July 1, 2020 | April 30, 2025 | MATAS, ARTHUR J | reporter.nih.gov |
| HLA Immunogenetics and kidney allograft outcomes | NIH | National Institute of Allergy and Infectious Diseases | 2023 to 2025 | $2,338,883 | November 21, 2022 | October 31, 2027 | KAMOUN, MALEK | reporter.nih.gov |
| Computer-Assisted Histologic Evaluation of Cardiac Allograft Rejection | NIH | National Heart, Lung, and Blood Institute | 2021 to 2023 | $2,335,528 | September 1, 2020 | August 31, 2025 | MARGULIES, KENNETH BER | reporter.nih.gov |
| The Synthetic Kidney: A Revolutionary Solution for the Shortage of Kidneys for Transplantation | NIH | National Institute of Diabetes and Digestive and Kidney Diseases | 2022 to 2025 | $2,335,138 | September 15, 2022 | August 31, 2027 | LI, ZHONGWEI | reporter.nih.gov |
| Lymph Node Delivery in Transplantation | NIH | National Institute of Allergy and Infectious Diseases | 2022 to 2025 | $2,334,750 | June 18, 2022 | May 31, 2027 | ABDI, REZA | reporter.nih.gov |
| The Impact of Structural Racism on Racial/Ethnic Disparities in End-Stage Kidney Disease from Healthy Population to Mortality | NIH | National Institute of Diabetes and Digestive and Kidney Diseases | 2022 to 2024 | $2,304,849 | August 1, 2022 | April 29, 2025 | DAW, JONATHAN KYLE | reporter.nih.gov |
| Multi-omic Biomarker Discovery and Validation in Heart Transplant Patient Populations | NIH | National Institute of Allergy and Infectious Diseases | 2021 to 2023 | $2,294,125 | March 1, 2020 | June 30, 2023 | KEATING, BRENDAN JAMES | reporter.nih.gov |
| HuR/HIF – SIRT1 Signaling Axis in Liver Transplant Rejuvenation | NIH | National Institute of Diabetes and Digestive and Kidney Diseases | 2021 to 2025 | $2,287,369 | April 1, 2003 | March 31, 2027 | KUPIEC-WEGLINSKI, JERZY W | reporter.nih.gov |
| The Role of Donor-Derived Eosinophils on Lung Allograft Ischemia Reperfusion Injury | NIH | National Institute of Allergy and Infectious Diseases | 2021 to 2025 | $2,276,035 | February 1, 2019 | August 31, 2030 | KRUPNICK, ALEXANDER S. | reporter.nih.gov |
| IRI, innate immunity and transplant rejection | NIH | National Institute of Allergy and Infectious Diseases | 2021 to 2025 | $2,266,791 | March 15, 2021 | February 28, 2026 | ABDI, REZA | reporter.nih.gov |
| Liver Xenotransplantation using CRISPR-modified Porcine Organs | NIH | National Institute of Allergy and Infectious Diseases | 2021 to 2023 | $2,264,625 | February 1, 2020 | December 1, 2023 | MARKMANN, JAMES FRANCIS | reporter.nih.gov |
| Preparation for lung transplant discussions and decisions among people with cystic fibrosis | NIH | National Institute of Nursing Research | 2023 to 2025 | $2,255,861 | April 19, 2023 | January 31, 2028 | RAMOS, KATHLEEN JESSICA | reporter.nih.gov |
| Genetic Testing (APOL1) Decisional Support for Potential Living Kidney Donors | NIH | National Institute of Diabetes and Digestive and Kidney Diseases | 2021 to 2024 | $2,255,854 | September 30, 2021 | April 30, 2026 | GARDINER, HEATHER MARIE | reporter.nih.gov |
| The impact of body composition on peri-operative and patient-centered outcomes in lung transplantation. | NIH | National Heart, Lung, and Blood Institute | 2022 to 2025 | $2,249,248 | August 5, 2022 | July 31, 2027 | SINGER, JONATHAN PAUL | reporter.nih.gov |
| Tissue resident memory T cells and chronic lung allograft dysfunction | NIH | National Heart, Lung, and Blood Institute | 2023 to 2025 | $2,220,732 | July 20, 2023 | April 30, 2028 | SNYDER, MARK EUGENE | reporter.nih.gov |
| Intra-graft C1 esterase inhibitor therapy for deceased kidney transplantation | NIH | National Institute of Allergy and Infectious Diseases | 2024 | $2,216,525 | September 1, 2024 | August 31, 2031 | HEEGER, PETER SCOTT | reporter.nih.gov |
| Intra-graft C1 esterase inhibitor therapy for deceased kidney transplantation | NIH | National Institute of Allergy and Infectious Diseases | 2025 | $2,216,525 | September 1, 2024 | August 31, 2031 | HEEGER, PETER SCOTT | reporter.nih.gov |
| Investigating the role of frailty on outcomes in acutely ill patients with cirrhosis undergoing liver transplantation in the acute care setting | NIH | National Institute of Diabetes and Digestive and Kidney Diseases | 2023 to 2025 | $2,213,082 | July 15, 2023 | April 30, 2028 | LAI, JENNIFER C. | reporter.nih.gov |
| Lung transplant injury drives chronic lung allograft dysfunction via recruitment ofmonocyte-derived alveolar macrophages | NIH | National Heart, Lung, and Blood Institute | 2021 to 2023 | $2,211,115 | September 1, 2020 | August 31, 2024 | MISHARIN, ALEXANDER | reporter.nih.gov |
| Complement-Mediated Exosome Function in Transplantation | NIH | National Institute of Allergy and Infectious Diseases | 2022 to 2025 | $2,152,526 | September 22, 2022 | July 31, 2027 | CHUN, NICHOLAS | reporter.nih.gov |
| Innate Allorecognition in Clinical Organ Transplantation | NIH | National Institute of Allergy and Infectious Diseases | 2023 to 2025 | $2,152,469 | December 20, 2022 | June 30, 2025 | LAKKIS, FADI G. | reporter.nih.gov |
| Targeting the transcriptional co-activators YAP and TAZ with statins to prevent solid organ transplant rejection by HLA donor specific antibodies | NIH | National Institute of Allergy and Infectious Diseases | 2023 to 2025 | $2,144,831 | July 19, 2023 | June 30, 2028 | REED, ELAINE F | reporter.nih.gov |
| Non-APOL1 genetic factors and kidney transplant outcomes | NIH | National Institute of Diabetes and Digestive and Kidney Diseases | 2023 to 2025 | $2,142,442 | August 15, 2023 | May 31, 2028 | KIRYLUK, KRZYSZTOF | reporter.nih.gov |
| Integrated analysis of HCC CTCs for Liver Transplant Candidate Selection | NIH | National Cancer Institute | 2021 to 2024 | $2,139,039 | April 1, 2020 | March 31, 2026 | AGOPIAN, VATCHE | reporter.nih.gov |
| The Role of Telomeres in Lung Transplant Recipient Immunity and Outcomes | NIH | National Heart, Lung, and Blood Institute | 2023 to 2025 | $2,129,020 | March 5, 2023 | February 29, 2028 | MCDYER, JOHN F | reporter.nih.gov |
| Development of a Fully-Implantable Ventricular Assist Device for Neonates and Children with Heart Failure - with Magnetic Levitation to Improve Hemocompatibility | NIH | National Heart, Lung, and Blood Institute | 2021 to 2023 | $2,115,146 | August 1, 2020 | June 30, 2025 | FRAZIER, O. H. | reporter.nih.gov |
| Engineering synthetic cellular crosstalk for transplantation tolerance | NIH | National Institute of Allergy and Infectious Diseases | 2022 to 2025 | $2,109,666 | February 1, 2022 | January 31, 2027 | MA, LEYUAN | reporter.nih.gov |
| Non-Invasive Venous waveform Analysis (NIVA) for Monitoring Volume Status in Heart Failure Patients | NIH | National Heart, Lung, and Blood Institute | 2021 to 2025 | $2,103,997 | August 1, 2019 | June 30, 2029 | ALVIS, BRET D. | reporter.nih.gov |
| Role of Eosinophils in Hepatic Ischemia Reperfusion Injury | NIH | National Institute of Diabetes and Digestive and Kidney Diseases | 2021 to 2025 | $2,103,519 | June 1, 2019 | March 31, 2027 | JU, CYNTHIA | reporter.nih.gov |
| High subzero heart preservation: from zebrafish to mammals | NIH | National Heart, Lung, and Blood Institute | 2021 to 2025 | $2,100,000 | April 1, 2021 | March 31, 2027 | TESSIER, SHANNON NOELLA | reporter.nih.gov |
| Reaching Equity for Adults and CHildren in Transplant (REACH-TRANSPLANT) | NIH | National Institute of Diabetes and Digestive and Kidney Diseases | 2021 to 2023 | $2,085,721 | September 11, 2019 | June 30, 2025 | KU, ELAINE | reporter.nih.gov |
| A place-based approach to geographic disparities in lung transplant | NIH | National Heart, Lung, and Blood Institute | 2023 to 2025 | $2,075,369 | August 1, 2023 | May 31, 2028 | TSUANG, WAYNE M | reporter.nih.gov |
| PET Tracer for Imaging of Lung Inflammation | NIH | National Heart, Lung, and Blood Institute | 2023 to 2025 | $2,072,841 | September 1, 2023 | May 31, 2027 | SHARMA, VIJAY | reporter.nih.gov |
| Dissecting the role of dynamic epigenome prompting pathways leading to kidney allograft fibrosis | NIH | National Institute of Diabetes and Digestive and Kidney Diseases | 2021 to 2023 | $2,062,322 | July 1, 2019 | June 30, 2025 | MAS, VALERIA RAQUEL | reporter.nih.gov |
| Novel Kidney Injury Tools in Deceased Organ Donation to Predict Graft Outcomes | NIH | National Institute of Diabetes and Digestive and Kidney Diseases | 2023 to 2025 | $2,054,144 | August 15, 2012 | November 30, 2026 | PARIKH, CHIRAG R | reporter.nih.gov |
| Long-acting injectable tacrolimus for chronic immunosuppression | NIH | National Institute of Allergy and Infectious Diseases | 2022 to 2023 | $2,047,614 | July 8, 2022 | June 30, 2025 | SMITH, THOMAS J. | reporter.nih.gov |
| Neuropilin-2 in Alloimmunity | NIH | National Institute of Allergy and Infectious Diseases | 2021 to 2024 | $2,036,192 | March 1, 2020 | February 28, 2026 | BRISCOE, DAVID M. | reporter.nih.gov |
| Chronic Versus Acute Transplantation of Neural Tissues for TBI-Induced Cortical Injuries | NIH | National Institute of Neurological Disorders and Stroke | 2021 to 2025 | $2,031,527 | July 1, 2021 | June 30, 2027 | CHEN, HAN-CHIAO ISAAC | reporter.nih.gov |
| Senescent cells drive mt-DNA accumulation and inflamm-aging | NIH | National Institute on Aging | 2021 to 2024 | $2,028,164 | June 15, 2020 | April 30, 2026 | TULLIUS, STEFAN GUNTHER | reporter.nih.gov |
| Fecal Microbiota Transplant for C. difficile Infection in Solid Organ Transplant Recipients | NIH | National Institute of Allergy and Infectious Diseases | 2021 to 2022 | $2,027,511 | September 15, 2018 | August 31, 2023 | SAFDAR, NASIA | reporter.nih.gov |
| Continuous allocation score design for guaranteeing equity and reducing discards in kidney and liver transplantation | NIH | National Institute of Diabetes and Digestive and Kidney Diseases | 2023 to 2025 | $2,022,974 | December 17, 2022 | November 30, 2027 | MASSIE, ALLAN B | reporter.nih.gov |
| Length-dependent activation in human myocardium | NIH | National Heart, Lung, and Blood Institute | 2021 to 2023 | $2,020,753 | September 15, 2020 | July 31, 2025 | CAMPBELL, KENNETH S | reporter.nih.gov |
| Mechanisms and Ex Vivo Repair of Cold-Storage Injury in Human Kidney Allografts | NIH | National Institute of Diabetes and Digestive and Kidney Diseases | 2021 to 2024 | $2,018,635 | February 28, 2020 | January 31, 2026 | POBER, JORDAN S | reporter.nih.gov |
| The novel role of HLA-E restricted CD8 regulatory T cells in kidney allograft rejection | NIH | National Institute of Allergy and Infectious Diseases | 2023 to 2025 | $2,004,858 | July 12, 2023 | June 30, 2028 | AZZI, JAMIL | reporter.nih.gov |
| Extended preservation of human livers: a nature inspired, high subzero controlled, limited freezing approach | NIH | National Institute of Diabetes and Digestive and Kidney Diseases | 2022 to 2024 | $1,992,855 | September 13, 2019 | August 31, 2025 | BAICU, SIMONA C | reporter.nih.gov |
| Neonatal and Young Pediatric Kidney Preservation through Nanowarming and Vitrification | NIH | National Institute of Allergy and Infectious Diseases | 2024 to 2025 | $1,991,119 | September 14, 2018 | June 30, 2027 | WEEGMAN, BRADLEY P | reporter.nih.gov |
| Local regulation and deletion of T cells to induce tolerance and establish long-term survival of high-risk corneal transplants | NIH | National Eye Institute | 2021 to 2025 | $1,990,241 | April 1, 2020 | February 28, 2030 | LEVY, ROBERT BENJAMIN | reporter.nih.gov |
| Greatly Extended Subzero Ischemic Storage of Renal Allografts Using Novel Bio-inspired Next Generation Cryoprotectants | NIH | National Institute of Diabetes and Digestive and Kidney Diseases | 2023 to 2024 | $1,986,927 | August 1, 2023 | May 31, 2026 | KLINE, MARK A | reporter.nih.gov |
| Improving marginal allograft outcomes through cell junction stabilization in transplantation | NIH | National Institute of Diabetes and Digestive and Kidney Diseases | 2021 to 2022 | $1,981,284 | April 15, 2020 | March 31, 2024 | GREK, CHRISTINA | reporter.nih.gov |
| Racial disparities in access to kidney transplantation | NIH | National Institute of Diabetes and Digestive and Kidney Diseases | 2021 to 2025 | $1,967,199 | December 6, 2017 | March 31, 2029 | KU, ELAINE | reporter.nih.gov |
| Urgent and unmet need for a long-term solution for increasing pediatric heart-failure population: BiVACOR Rotary Total Artificial Heart | NIH | National Heart, Lung, and Blood Institute | 2021 to 2023 | $1,965,590 | August 5, 2021 | July 31, 2025 | TIMMS, DANIEL | reporter.nih.gov |
| Isochoric Pressure Based Preservation of Ovarian Tissue | NIH | Eunice Kennedy Shriver National Institute of Child Health & Human Development | 2021 to 2023 | $1,958,572 | September 26, 2016 | September 30, 2023 | WEEGMAN, BRADLEY P | reporter.nih.gov |
| Targeting Immune-Responsive Gene 1 (Irg1) and Itaconate for Cardioprotection of the Donor Heart for Transplantation | NIH | National Heart, Lung, and Blood Institute | 2023 to 2025 | $1,957,180 | August 1, 2023 | July 31, 2027 | TANG, PAUL | reporter.nih.gov |
| VisR Ultrasound for Monitoring Antibody-Mediated Rejection in Renal Transplant Patients | NIH | National Institute of Diabetes and Digestive and Kidney Diseases | 2023 to 2025 | $1,948,258 | March 1, 2016 | November 30, 2027 | GALLIPPI, CATERINA M | reporter.nih.gov |
| Enhanced supercooling for extending non-freezing preservation in preclinical porcine and human donor livers | NIH | National Institute of Diabetes and Digestive and Kidney Diseases | 2024 to 2025 | $1,946,161 | September 17, 2024 | June 30, 2027 | TAYLOR, MICHAEL JOHN | reporter.nih.gov |
| Improving Utilization of Live Donor Kidney Transplant through Effective Patient-Provider Communication | NIH | National Institute of Diabetes and Digestive and Kidney Diseases | 2023 to 2025 | $1,936,004 | June 5, 2023 | May 31, 2027 | SIMINOFF, LAURA A. | reporter.nih.gov |
| Cryopreservation and nanowarming enables whole liver banking for transplantation, cell therapy and biomedical research | NIH | National Institute of Diabetes and Digestive and Kidney Diseases | 2023 to 2025 | $1,931,299 | February 15, 2023 | January 31, 2027 | FINGER, ERIK BRIAN | reporter.nih.gov |
| Impact of Microbiota on Alloimmune Responses in Transplantation | NIH | National Institute of Allergy and Infectious Diseases | 2021 to 2024 | $1,921,704 | November 3, 2014 | November 30, 2025 | ALEGRE, MARIA-LUISA | reporter.nih.gov |
| Donor Kidney Resident Macrophages in Kidney Allograft Early Inflammation and Alloimmunity | NIH | National Institute of Diabetes and Digestive and Kidney Diseases | 2022 to 2025 | $1,919,356 | April 1, 2022 | February 28, 2027 | LUO, XUNRONG | reporter.nih.gov |
| The Role of Donor Innate Immune Responses in Regulating Alloimmunity after Heart Transplantation | NIH | National Heart, Lung, and Blood Institute | 2021 to 2023 | $1,907,359 | June 1, 2020 | May 31, 2025 | KREISEL, DANIEL | reporter.nih.gov |
| Genetic engineering of kidney allografts by ex vivo perfusion delivery of adeno-associated viral vectors | NIH | National Institute of Allergy and Infectious Diseases | 2022 to 2025 | $1,903,303 | July 19, 2022 | April 30, 2027 | BARBAS, ANDREW SERGHIOS | reporter.nih.gov |
| Informing Ethical Translation of Xenotransplantation Clinical Trials | NIH | National Center for Advancing Translational Sciences | 2021 to 2024 | $1,895,092 | August 9, 2021 | July 31, 2025 | MASCHKE, KAREN JOANN | reporter.nih.gov |
| T Cell Memory in Organ Transplantation | NIH | National Institute of Allergy and Infectious Diseases | 2021 to 2024 | $1,873,569 | February 1, 2001 | April 30, 2026 | LAKKIS, FADI G. | reporter.nih.gov |
| Peri-operative factors that drive cell-free hemoglobin-mediated primary graft dysfunction | NIH | National Heart, Lung, and Blood Institute | 2022 to 2025 | $1,864,753 | August 5, 2022 | July 31, 2027 | SHAVER, CIARA M | reporter.nih.gov |
| Long-term Outcomes after Interventions for Congenital Heart Disease | NIH | National Heart, Lung, and Blood Institute | 2021 to 2022 | $1,858,355 | April 1, 2014 | July 31, 2025 | KOCHILAS, LAZAROS K. | reporter.nih.gov |
| Developing Machine Learning Models for Decision Support and Allocation Optimization in Heart Transplantation | NIH | National Heart, Lung, and Blood Institute | 2023 to 2025 | $1,857,171 | September 4, 2023 | March 31, 2027 | KILIC, ARMAN | reporter.nih.gov |
| Multifaceted Intervention to Improve Graft Outcome Disparities in African American Kidney Transplants (MITIGAAT) | NIH | National Institute of Diabetes and Digestive and Kidney Diseases | 2023 to 2025 | $1,835,791 | July 1, 2023 | May 31, 2028 | TABER, DAVID J. | reporter.nih.gov |
| Circadian Signatures in Chronic Lung Disease | NIH | National Heart, Lung, and Blood Institute | 2021 to 2023 | $1,833,797 | August 1, 2020 | May 31, 2025 | HASPEL, JEFFREY ADAM | reporter.nih.gov |
| Improving Lung Transplant Outcomes with Coping Skills and Physical Activity | NIH | National Institute of Nursing Research | 2021 to 2023 | $1,828,423 | May 9, 2019 | February 28, 2026 | PALMER, SCOTT M | reporter.nih.gov |
| The Gut Microbiome and Serum Metabolites as a Biological Mechanism Underlying Pain in Kidney Transplantation (Biome-KT) | NIH | National Institute of Diabetes and Digestive and Kidney Diseases | 2023 to 2025 | $1,824,012 | May 15, 2023 | February 29, 2028 | LOCKWOOD, MARK | reporter.nih.gov |
| Microbial Dysbiosis in Chronic Lung Allograft Dysfunction | NIH | National Heart, Lung, and Blood Institute | 2022 to 2025 | $1,799,138 | August 1, 2022 | September 5, 2025 | SHARMA, NIRMAL S | reporter.nih.gov |
| The Clinical and Molecular Impacts of Lung Primary Graft Dysfunction | NIH | National Heart, Lung, and Blood Institute | 2022 to 2025 | $1,778,203 | August 5, 2022 | July 31, 2027 | MCDYER, JOHN F | reporter.nih.gov |
| Optimizing Donor Management in Lung Transplantation | NIH | National Heart, Lung, and Blood Institute | 2021 to 2025 | $1,777,381 | July 1, 2020 | March 31, 2030 | PURI, VARUN | reporter.nih.gov |
| Pre-Transplant Monocyte HDAC6 Expression and Risk of Primary Graft Dysfunction in Clinical Lung Transplant Recipients | NIH | National Heart, Lung, and Blood Institute | 2021 to 2024 | $1,760,510 | December 15, 2020 | November 30, 2024 | HANCOCK, WAYNE WILLIAM | reporter.nih.gov |
| The Role of Ischemia Reperfusion Injury in Lung Allograft Rejection | NIH | National Heart, Lung, and Blood Institute | 2021 to 2025 | $1,756,518 | September 2, 2009 | February 28, 2030 | KREISEL, DANIEL | reporter.nih.gov |
| Lung transplant recipient exosome phenotypes and the risk of primary graft dysfunction and acute lung allograft dysfunction | NIH | National Heart, Lung, and Blood Institute | 2022 to 2025 | $1,747,905 | August 5, 2022 | July 31, 2027 | MULLIGAN, MICHAEL SCOTT | reporter.nih.gov |
| Gut Microbiota and Effect on Immune Suppressants in Transplantation | NIH | National Institute of Allergy and Infectious Diseases | 2021 to 2024 | $1,744,183 | February 1, 2019 | September 3, 2024 | ISRANI, AJAY K | reporter.nih.gov |
| Living Donor Extended Time Outcomes (LETO) Study | NIH | National Institute of Diabetes and Digestive and Kidney Diseases | 2021 to 2023 | $1,740,456 | June 1, 2019 | May 31, 2025 | HSU, CHI-YUAN | reporter.nih.gov |
| 1/4-American Consortium of Early Liver Transplantation-Prospective Alcohol-associated liver disease Cohort Evaluation (ACCELERATE-PACE) | NIH | National Institute on Alcohol Abuse and Alcoholism | 2023 to 2025 | $1,732,406 | August 1, 2023 | July 31, 2030 | TERRAULT, NORAH A. | reporter.nih.gov |
| A Noninvasive Integrated Genomic Approach for Early Cancer Detection and Risk Stratification after Transplantation | NIH | National Cancer Institute | 2021 to 2023 | $1,728,199 | March 1, 2019 | February 29, 2024 | KHUSH, KIRAN KAUR | reporter.nih.gov |
| Understanding the immune response changes to clinical interventions for Epstein-Barr virus infection prior to lymphoma development in children after organ transplants (UNEARTH) | NIH | National Cancer Institute | 2024 to 2025 | $1,709,513 | September 1, 2023 | August 31, 2028 | DHARNIDHARKA, VIKAS R. | reporter.nih.gov |
| Vaccination responses in lung transplant recipients | NIH | National Heart, Lung, and Blood Institute | 2022 to 2025 | $1,708,641 | August 5, 2022 | July 31, 2027 | NICOLLS, MARK ROBERT | reporter.nih.gov |
| Investigating Donor Authorization and Public Perceptions of Normothermic Regional Perfusion to Inform Ethical Organ Donation Practices | NIH | National Heart, Lung, and Blood Institute | 2024 to 2025 | $1,703,234 | August 21, 2025 | February 28, 2029 | PARENT, BRENDAN | reporter.nih.gov |
| Optimizing the allocation of hearts from deceased donors | NIH | National Heart, Lung, and Blood Institute | 2024 to 2025 | $1,694,985 | April 11, 2024 | January 31, 2028 | GENTRY, SOMMER ELIZABETH | reporter.nih.gov |
| AI-LIVER: Advancing Liver Transplantation through AI-Driven Outcome Prognostication and Normothermic Perfusion Data Exchange | NIH | National Institute of Biomedical Imaging and Bioengineering | 2025 | $1,694,532 | September 1, 2025 | August 31, 2028 | IRIZAR, ARITZ | reporter.nih.gov |
| Computational Image Analysis of Renal Transplant Biopsies to Predict Graft Outcome | NIH | National Institute of Diabetes and Digestive and Kidney Diseases | 2023 to 2025 | $1,694,166 | September 6, 2023 | July 31, 2028 | SARDER, PINAKI | reporter.nih.gov |
| Donor-specific B cells in Transplantation | NIH | National Institute of Allergy and Infectious Diseases | 2021 to 2024 | $1,692,498 | September 22, 2020 | October 31, 2024 | CASCALHO, MARILIA ISABEL | reporter.nih.gov |
| AI-empowered 3D Computer Vision and Image-Omics Integration for Digital Kidney Histopathology | NIH | National Institute of Diabetes and Digestive and Kidney Diseases | 2023 to 2025 | $1,690,756 | March 15, 2023 | December 31, 2027 | HUO, YUANKAI | reporter.nih.gov |
| Bioengineering a chimeric human lung | NIH | National Heart, Lung, and Blood Institute | 2021 to 2022 | $1,684,888 | August 7, 2013 | June 30, 2024 | VUNJAK-NOVAKOVIC, GORDANA | reporter.nih.gov |
| Evaluation of a mobile app-based video Directly Observed Therapy (video DOT) intervention for medication adherence in pediatric heart transplant patients | NIH | National Heart, Lung, and Blood Institute | 2023 to 2024 | $1,676,046 | April 1, 2023 | March 31, 2026 | SEIGUER, SEBASTIAN | reporter.nih.gov |
| Defining cellular mechanisms of chronic graft failure in transplanted hearts with single cell multi-omics | NIH | National Heart, Lung, and Blood Institute | 2022 to 2025 | $1,675,407 | April 20, 2022 | March 31, 2026 | GAO, RULI | reporter.nih.gov |
| Clinical and Biological Factors Predicting Lung Transplant Textbook Outcomes (U01) | NIH | National Heart, Lung, and Blood Institute | 2022 to 2025 | $1,673,463 | August 5, 2022 | July 31, 2027 | SNYDER, LAURIE D | reporter.nih.gov |
| Mechanistic studies on pregnancy-induced humoral sensitization in organ transplantation | NIH | National Institute of Allergy and Infectious Diseases | 2024 to 2025 | $1,659,240 | June 3, 2024 | April 30, 2029 | CHONG, ANITA S | reporter.nih.gov |
| Mechanisms of action, optimization and application of Bregs | NIH | National Institute of Allergy and Infectious Diseases | 2021 to 2023 | $1,655,547 | January 1, 2006 | December 1, 2023 | MARKMANN, JAMES FRANCIS | reporter.nih.gov |
| Chronic Lung Allograft Dysfunction: Role for Tumor Suppressor LKB1 in Exosomes | NIH | National Heart, Lung, and Blood Institute | 2022 to 2025 | $1,649,563 | June 15, 2022 | May 31, 2027 | MOHANAKUMAR, THALACHALLOUR | reporter.nih.gov |
| Immune repertoire remodeling following B cell-targeted CAR T cells for induction of renal allograft tolerance in non-human primates | NIH | National Institute of Allergy and Infectious Diseases | 2025 | $1,648,086 | May 13, 2025 | April 30, 2030 | NAJI, ALI | reporter.nih.gov |
| Pre-transplant health coaching to improve patient-reported outcomes in lung transplant candidates | NIH | National Heart, Lung, and Blood Institute | 2023 to 2025 | $1,632,733 | May 15, 2022 | April 30, 2027 | KENNEDY, CASSIE COLLEEN | reporter.nih.gov |
| Optimizing Preimplantation Kidney Transplant Biopsy Interpretation with Artificial Intelligence Assistance - Resubmission - 1 | NIH | National Institute of Diabetes and Digestive and Kidney Diseases | 2024 to 2025 | $1,626,699 | September 5, 2024 | June 30, 2029 | SEGEV, DORRY L. | reporter.nih.gov |
| Computational Drug Repositioning for Antibody Mediated Renal Allograft Rejection | NIH | National Institute of Allergy and Infectious Diseases | 2024 to 2025 | $1,614,752 | June 28, 2024 | April 30, 2029 | SARWAL, MINNIE M | reporter.nih.gov |
| Protection of donor kidneys with synchronization modulation electric field (SMEF) | NIH | National Institute of Diabetes and Digestive and Kidney Diseases | 2022 to 2023 | $1,607,477 | September 23, 2021 | July 31, 2025 | LIU, RUISHENG | reporter.nih.gov |
| Investigating a Novel Cellular Therapy to Prevent and Treat Acute Antibody Mediated Kidney Transplant Rejection | NIH | National Institute of Allergy and Infectious Diseases | 2021 to 2023 | $1,603,254 | July 1, 2019 | June 30, 2025 | BUMGARDNER, GINNY L | reporter.nih.gov |
| Novel mitochondrial protective properties of annexin A1 | NIH | National Institute of Diabetes and Digestive and Kidney Diseases | 2021 to 2025 | $1,597,120 | September 22, 2021 | June 30, 2027 | PRIVRATSKY, JAMIE R | reporter.nih.gov |
| Promoting and Visualizing Immune Regulation in Transplantation | NIH | National Institute of Allergy and Infectious Diseases | 2022 to 2025 | $1,593,227 | June 13, 2022 | March 31, 2027 | CAMIRAND, GEOFFREY | reporter.nih.gov |
| CATCH: Creating Access to Transplant for Candidates who are High Risk | NIH | National Heart, Lung, and Blood Institute | 2022 to 2025 | $1,592,826 | August 5, 2022 | July 31, 2027 | KESHAVJEE, SHAF | reporter.nih.gov |
| Microbial Biomarkers for Diagnosing and Predicting Infections in Kidney Transplant Recipients | NIH | National Institute of Allergy and Infectious Diseases | 2024 to 2025 | $1,588,564 | May 24, 2024 | March 31, 2029 | LEE, JOHN RICHARD | reporter.nih.gov |
| Intestinal allograft tolerance in large animals | NIH | National Institute of Allergy and Infectious Diseases | 2021 to 2022 | $1,585,355 | February 8, 2018 | January 31, 2023 | SYKES, MEGAN | reporter.nih.gov |
| Complementary pathways of necroptosis in recipient and donor lung tissue that drive primary lung allograft dysfunction | NIH | National Heart, Lung, and Blood Institute | 2024 to 2025 | $1,584,308 | September 1, 2024 | June 30, 2029 | BHARAT, ANKIT | reporter.nih.gov |
| The first clinical use of the BiVACOR Total Artificial Heart | NIH | National Heart, Lung, and Blood Institute | 2023 | $1,569,477 | August 1, 2023 | July 31, 2026 | TIMMS, DANIEL | reporter.nih.gov |
| Novel Mechanisms of Hepatopulmonary Syndrome | NIH | National Heart, Lung, and Blood Institute | 2021 to 2022 | $1,567,158 | June 1, 2018 | April 30, 2025 | KAWUT, STEVEN M | reporter.nih.gov |
| The RaDIANT Health Systems Intervention for Improving Access to Kidney Transplantation | NIH | National Institute of Diabetes and Digestive and Kidney Diseases | 2023 to 2025 | $1,563,640 | July 1, 2023 | May 31, 2028 | PATZER, RACHEL E | reporter.nih.gov |
| THE RELAXIN RECEPTOR GR/RXFP1 SIGNALING IN LIVER TRANSPLANT ISCHEMIA-REPERFUSION INJURY AND THE INFLAMMATION RESOLUTION | NIH | National Institute of Allergy and Infectious Diseases | 2021 to 2024 | $1,560,000 | September 22, 2020 | August 31, 2025 | KUPIEC-WEGLINSKI, JERZY W | reporter.nih.gov |
| Mechanisms of microbiome-driven cardiac allograft outcomes | NIH | National Institute of Allergy and Infectious Diseases | 2022 to 2025 | $1,545,000 | May 13, 2022 | April 30, 2027 | MA, BING | reporter.nih.gov |
| Using Advanced Imaging to Improve Ex Vivo Lung Perfusion | NIH | National Heart, Lung, and Blood Institute | 2024 to 2025 | $1,544,220 | September 17, 2024 | June 30, 2028 | RIZI, RAHIM R | reporter.nih.gov |
| Avoiding Cardiovascular Complications in Liver Transplantation through Novel Studies (ACCT NOW) in Hypertension | NIH | National Heart, Lung, and Blood Institute | 2024 to 2025 | $1,533,772 | August 15, 2024 | May 31, 2027 | VANWAGNER, LISA B | reporter.nih.gov |
| Defining the microenvironment that will enable a long-term bioprosthetic ovary transplant | NIH | Eunice Kennedy Shriver National Institute of Child Health & Human Development | 2021 to 2025 | $1,533,689 | May 1, 2021 | April 30, 2027 | LARONDA, MONICA M | reporter.nih.gov |
| Cardiac MRI Increases Accuracy and Decreases Risk of Evaluation of Children with Cardiomyopathy and Cardiac Transplantation | NIH | National Heart, Lung, and Blood Institute | 2021 to 2022 | $1,533,577 | February 15, 2019 | April 8, 2022 | OLIVIERI, LAURA J | reporter.nih.gov |
| TNFRSF13B polymorphisms and immunity to transplantation | NIH | National Institute of Allergy and Infectious Diseases | 2025 | $1,533,577 | August 15, 2023 | July 31, 2028 | CASCALHO, MARILIA ISABEL | reporter.nih.gov |
| Developing High-Quality Tools to Characterize Allograft Quality, Predict Transplant Outcomes and Expand Access to Kidney and Liver Transplantation | NIH | National Institute of Diabetes and Digestive and Kidney Diseases | 2021 to 2023 | $1,531,598 | July 1, 2020 | April 30, 2025 | REESE, PETER PHILIP | reporter.nih.gov |
| Translational development and clinical evaluation of a bioengineered human lung graft for clinical transplantation | NIH | National Heart, Lung, and Blood Institute | 2025 | $1,515,926 | September 8, 2025 | June 30, 2027 | O'NEILL, JOHN DAVID | reporter.nih.gov |
| Improving access to renal transplantation for Underserved Black Communities | NIH | National Institute of Diabetes and Digestive and Kidney Diseases | 2023 to 2024 | $1,511,543 | September 1, 2023 | April 30, 2025 | LADNER, DANIELA P | reporter.nih.gov |
| Improving Kidney Transplant Outcomes and Reducing Costs of Care through Better Pretransplant Operations | NIH | National Institute of Diabetes and Digestive and Kidney Diseases | 2025 | $1,500,424 | September 15, 2025 | August 31, 2029 | CHENG, XINGXING SHELLEY | reporter.nih.gov |
| Using ethics, epidemiology and high-quality data to optimize the allocation of livers for transplantation | NIH | National Institute of Diabetes and Digestive and Kidney Diseases | 2021 to 2023 | $1,498,133 | April 1, 2019 | March 31, 2025 | GOLDBERG, DAVID SETH | reporter.nih.gov |
| Role of plasma cells in chronic rejection after lung transplantation | NIH | National Heart, Lung, and Blood Institute | 2024 to 2025 | $1,494,478 | September 2, 2024 | May 31, 2028 | EICKELBERG, OLIVER | reporter.nih.gov |
| RhoFED T-SCCC | NIH | National Institute of Allergy and Infectious Diseases | 2023 | $1,494,050 | May 5, 2023 | April 30, 2025 | ARMSTRONG, BRIAN | reporter.nih.gov |
| Cross-Disease Multi-Modality Mapping of the Human Lung | NIH | National Heart, Lung, and Blood Institute | 2024 to 2025 | $1,491,262 | September 1, 2024 | August 31, 2029 | SUN, XIN | reporter.nih.gov |
| Innovation of Skin Banking and Transplantation Based on a First-in-Class Biocompatible Cryopreservation Technology | NIH | National Institute of Allergy and Infectious Diseases | 2022 to 2023 | $1,487,801 | May 6, 2022 | April 30, 2025 | HAN, XU | reporter.nih.gov |
| Mitigating Ischemia-Reperfusion Injury to Reduce Early Damage to Intestinal Allografts | NIH | National Institute of Allergy and Infectious Diseases | 2024 to 2025 | $1,482,086 | February 1, 2024 | December 31, 2028 | GONZALEZ, LIARA M | reporter.nih.gov |
| Mechanisms and Therapeutic Targeting of T cell Regulation in Heart Allograft Recipient Monkeys | NIH | National Institute of Allergy and Infectious Diseases | 2024 to 2025 | $1,472,359 | March 6, 2024 | January 31, 2029 | EZZELARAB, MOHAMED B | reporter.nih.gov |
| Developing Hyperpolarized Gas MRI signatures to detect and manage acute cellular rejection | NIH | National Heart, Lung, and Blood Institute | 2024 to 2025 | $1,471,438 | September 1, 2024 | May 31, 2029 | MATA, JAIME | reporter.nih.gov |
| EARLY SIGNALS OF THE TRANSITION FROM IMMUNE QUIESCENCE TO ACTIVATION IN THE LIVER ALLOGRAFT MICROENVIRONMENT AND IN THE CIRCULATION | NIH | National Institute of Allergy and Infectious Diseases | 2025 | $1,468,517 | August 4, 2025 | June 30, 2030 | FENG, SANDY | reporter.nih.gov |
| Mixed chimerism induced tolerance in heart recipients requires donor kidney cotransplantation | NIH | National Institute of Allergy and Infectious Diseases | 2021 to 2022 | $1,467,633 | June 1, 2017 | May 31, 2023 | MADSEN, JOREN C | reporter.nih.gov |
| Applying precision MEdicine to optimize desensitization with noveL bIOlogics or cellular theRApies in highly sensiTized kidney transplant patiEnts (AMELIORATE) | NIH | National Institute of Allergy and Infectious Diseases | 2021 to 2023 | $1,454,297 | August 5, 2014 | May 31, 2024 | VINCENTI, FLAVIO | reporter.nih.gov |
| PET Imaging of Renal Fibrosis | NIH | National Institute of Diabetes and Digestive and Kidney Diseases | 2024 to 2025 | $1,447,749 | September 20, 2024 | June 30, 2029 | CARAVAN, PETER D | reporter.nih.gov |
| Increasing Equity and Utility in Deceased Donor Kidney Allocation with HLA Molecular Matching | NIH | National Institute of Diabetes and Digestive and Kidney Diseases | 2024 to 2025 | $1,447,090 | March 1, 2024 | January 31, 2029 | MANKOWSKI, MICHAL A | reporter.nih.gov |
| Effects of Vaccination on Acute and Post-Acute Respiratory Viral Infection Outcomes in Solid Organ Transplant Recipients | NIH | National Institute of Allergy and Infectious Diseases | 2025 | $1,442,898 | June 13, 2025 | May 31, 2030 | WERBEL, WILLIAM | reporter.nih.gov |
| 12/14 APOL1 Long-term Kidney Transplantation Outcomes Network (APOLLO) Clinical Center | NIH | National Institute of Diabetes and Digestive and Kidney Diseases | 2022 to 2025 | $1,441,669 | September 25, 2017 | May 31, 2028 | HSU, CHI-YUAN | reporter.nih.gov |
| A quantitative viability metric for liver transplantation using Resonance Raman Spectroscopy | NIH | National Institute of Diabetes and Digestive and Kidney Diseases | 2023 to 2025 | $1,440,035 | April 15, 2023 | February 29, 2028 | TESSIER, SHANNON NOELLA | reporter.nih.gov |
| Regulatory Dendritic Cell Therapy in Live Donor Renal Transplant Recipients | NIH | National Institute of Allergy and Infectious Diseases | 2021 to 2022 | $1,429,279 | May 1, 2018 | April 30, 2025 | THOMSON, ANGUS W | reporter.nih.gov |
| A Rapid Point of Care Test for APOL1 Renal Risk Alleles | NIH | National Institute on Minority Health and Health Disparities | 2021 to 2022 | $1,426,406 | July 1, 2021 | February 29, 2024 | DARBY, MARTYN | reporter.nih.gov |
| Multi-Center Validation and Biologic Assessment of a Novel Pre-Transplant Biomarker Panel to Predict Liver Transplant Recipient Mortality | NIH | National Institute of Diabetes and Digestive and Kidney Diseases | 2024 to 2025 | $1,425,530 | September 20, 2024 | August 31, 2029 | LUNSFORD, KERI ELIZABETH | reporter.nih.gov |
| A modular cell therapy platform for controlling immunological tolerance | NIH | National Institute of Allergy and Infectious Diseases | 2023 to 2025 | $1,420,756 | August 4, 2023 | July 31, 2028 | RETICKER-FLYNN, NATHAN EDWARD | reporter.nih.gov |
| TARGETING HUMAN PLASMA CELLS TO OVERCOME HUMORAL RESPONSES IN TRANSPLANTATION | NIH | National Institute of Allergy and Infectious Diseases | 2021 to 2023 | $1,414,086 | December 17, 2018 | November 30, 2025 | DRISCOLL, JAMES JOSEPH | reporter.nih.gov |
| In Situ Skin Regeneration through Induction of Skin Allograft Chimerism for Treatment of Severe Burn Wounds | NIH | National Institute of Arthritis and Musculoskeletal and Skin Diseases | 2024 to 2025 | $1,409,229 | March 8, 2024 | January 31, 2029 | SUN, ZHAOLI | reporter.nih.gov |
| Estrogen and Serms as Therapy for Renal Ischemia Reperfusion Injury | NIH | National Institute of Diabetes and Digestive and Kidney Diseases | 2024 to 2025 | $1,408,439 | September 10, 2024 | August 31, 2028 | LEVINE, MATTHEW HOWARD | reporter.nih.gov |
| Age and Race Influences on Immunosuppression after Renal Transplant | NIH | National Institute on Aging | 2021 to 2022 | $1,393,926 | August 15, 2018 | June 30, 2026 | TORNATORE, KATHLEEN M | reporter.nih.gov |
| Rescuing Kidneys at Risk of Discard | NIH | National Institute of Diabetes and Digestive and Kidney Diseases | 2021 to 2022 | $1,390,768 | April 1, 2019 | March 31, 2025 | MEHROTRA, SANJAY | reporter.nih.gov |
| Pathogenesis of Restrictive Allograft Syndrome Post-Lung Transplantation | NIH | National Heart, Lung, and Blood Institute | 2022 to 2023 | $1,372,224 | December 1, 2021 | April 30, 2023 | LAMA, VIBHA N | reporter.nih.gov |
| Modulation of innate immune cells to create transplant tolerance | NIH | National Institute of Allergy and Infectious Diseases | 2021 to 2025 | $1,367,750 | March 1, 2011 | May 31, 2029 | LI, XIAN CHANG | reporter.nih.gov |
| Targeting Mineralocorticoid Receptor Condensates to Optimize Donor Heart Preservation | NIH | National Heart, Lung, and Blood Institute | 2024 to 2025 | $1,360,987 | December 15, 2022 | December 31, 2026 | TANG, PAUL | reporter.nih.gov |
| Novel Methods to Grow the Impact of Pediatric Thoracic Transplantation | NIH | National Heart, Lung, and Blood Institute | 2021 to 2022 | $1,360,349 | June 15, 2019 | June 30, 2024 | ZAFAR, FARHAN | reporter.nih.gov |
| Understanding Interorgan Communication Through Heterochronic Organ Transplantation | NIH | National Institute on Aging | 2024 to 2025 | $1,357,614 | June 1, 2024 | February 28, 2029 | GLADYSHEV, VADIM N. | reporter.nih.gov |
| Tissue-resident NK cell development and function in pregnancy and transplantation: lessons learned from human uterus transplant recipients | NIH | National Institute of Allergy and Infectious Diseases | 2024 to 2025 | $1,352,576 | June 6, 2024 | April 30, 2029 | PORRETT, PAIGE M | reporter.nih.gov |
| Targeting MicroRNA miR-122 for the Treatment of Perioperative Liver Injury | NIH | National Institute of Diabetes and Digestive and Kidney Diseases | 2021 to 2023 | $1,351,712 | May 11, 2020 | March 31, 2024 | JU, CYNTHIA | reporter.nih.gov |
| CKD Risk Prediction among Obese Living Kidney Donors | NIH | National Institute of Diabetes and Digestive and Kidney Diseases | 2021 to 2022 | $1,346,571 | December 1, 2017 | March 31, 2024 | LOCKE, JAYME ELIZABETH | reporter.nih.gov |
| Fractures and bone disease in living kidney donors | NIH | National Institute of Diabetes and Digestive and Kidney Diseases | 2021 to 2022 | $1,346,118 | July 9, 2020 | October 31, 2024 | KUMAR, RAJIV | reporter.nih.gov |
| Preservation and Rescue of The Lung Donor Allograft for Transplantation | NIH | National Heart, Lung, and Blood Institute | 2021 to 2022 | $1,345,066 | July 15, 2018 | December 31, 2024 | WHITSON, BRYAN A | reporter.nih.gov |
| MHC and KIR Sequencing and Association Analyses in the iGeneTRAiN Studies | NIH | National Institute of Allergy and Infectious Diseases | 2023 to 2024 | $1,337,288 | March 1, 2024 | June 30, 2025 | KEATING, BRENDAN JAMES | reporter.nih.gov |
| Protection of donor kidney and transplanted graft function by modulating Na/K ATPase activity | NIH | National Institute of Diabetes and Digestive and Kidney Diseases | 2024 to 2025 | $1,317,490 | April 1, 2024 | March 31, 2029 | LIU, RUISHENG | reporter.nih.gov |
| Assessment of Donor Quality for Improving Kidney Transplant Outcomes | NIH | National Institute of Diabetes and Digestive and Kidney Diseases | 2024 to 2025 | $1,316,733 | February 1, 2017 | January 31, 2028 | MAS, VALERIA RAQUEL | reporter.nih.gov |
| 2/4-The INTEGRATE Study: Evaluating INTEGRATEd care to Improve Biopschosocial Outcomes of Early Liver Transplantation for Alcohol-Associated Liver Disease | NIH | National Institute on Alcohol Abuse and Alcoholism | 2023 to 2025 | $1,314,963 | August 1, 2023 | July 31, 2030 | VERNA, ELIZABETH CLARICE | reporter.nih.gov |
| Telomere Dysfunction as a cause of Chronic Lung Allograft Dysfunction | NIH | National Heart, Lung, and Blood Institute | 2021 to 2024 | $1,314,271 | May 15, 2020 | April 30, 2026 | GREENLAND, JOHN | reporter.nih.gov |
| Trans-omics Analysis of African American Deceased Donor Kidneys for Transplant Outcomes. | NIH | National Institute of Diabetes and Digestive and Kidney Diseases | 2024 to 2025 | $1,304,338 | September 1, 2024 | June 30, 2028 | FREEDMAN, BARRY IRA | reporter.nih.gov |
| Macula densa NOS1 and transplanted renal graft function | NIH | National Institute of Diabetes and Digestive and Kidney Diseases | 2021 to 2024 | $1,302,444 | April 16, 2020 | March 31, 2026 | WANG, LEI | reporter.nih.gov |
| PCSK9 Inhibition after Heart Transplantation | NIH | National Heart, Lung, and Blood Institute | 2021 to 2023 | $1,294,106 | February 15, 2019 | March 31, 2026 | FEARON, WILLIAM F | reporter.nih.gov |
| Pathogenesis of Restrictive Allograft Syndrome Post-Lung Transplantation | NIH | National Heart, Lung, and Blood Institute | 2024 to 2025 | $1,291,538 | December 8, 2023 | November 30, 2026 | LAMA, VIBHA N | reporter.nih.gov |
| Preclinical Studies of Living and Deceased Donor Liver Allograft Tolerance | NIH | National Institute of Allergy and Infectious Diseases | 2025 | $1,286,273 | December 3, 2024 | November 30, 2029 | SYKES, MEGAN | reporter.nih.gov |
| Molecular mechanisms of post-transplant recurrent alcoholic liver disease | NIH | National Institute on Alcohol Abuse and Alcoholism | 2021 to 2025 | $1,286,113 | September 10, 2017 | March 31, 2028 | CARR, ROTONYA M | reporter.nih.gov |
| Ex Vivo Nanoparticle Drug Delivery Targeted to Human Allograft Endothelium | NIH | National Institute of Allergy and Infectious Diseases | 2024 to 2025 | $1,285,278 | September 1, 2024 | July 31, 2028 | POBER, JORDAN S | reporter.nih.gov |
| Role of DEPTOR in T Cell Activation and Alloimmunity | NIH | National Institute of Allergy and Infectious Diseases | 2021 to 2022 | $1,283,250 | December 8, 2017 | November 30, 2024 | BRISCOE, DAVID M. | reporter.nih.gov |
| Selective CD28 Blockade in Renal Transplant Recipients | NIH | National Institute of Allergy and Infectious Diseases | 2021 to 2022 | $1,277,249 | August 1, 2018 | July 31, 2025 | LARSEN, CHRISTIAN P. | reporter.nih.gov |
| 1/4-The INTEGRATE Study: Evaluating INTEGRATEd Care to Improve Biopsychosocial Outcomes of Early Liver Transplantation for Alcohol-Associated Liver Disease | NIH | National Institute on Alcohol Abuse and Alcoholism | 2023 to 2025 | $1,276,071 | August 1, 2023 | July 31, 2030 | VANWAGNER, LISA B | reporter.nih.gov |
| Immunobiology and Physiology of Liver xenograft in the Decedent | NIH | National Institute of Allergy and Infectious Diseases | 2025 | $1,273,991 | August 15, 2025 | July 31, 2030 | SHAKED, ABRAHAM NA | reporter.nih.gov |
| Transplantation of hearts from donation after circulatory death | NIH | National Heart, Lung, and Blood Institute | 2023 to 2025 | $1,264,837 | August 15, 2023 | May 31, 2027 | WANG, MEIJING | reporter.nih.gov |
| Systems analyses of induction and maintenance of immunity to SARS-CoV-2 vaccination in kidney transplant recipients receiving mycophenolate mofetil immunotherapy | NIH | National Institute of Allergy and Infectious Diseases | 2024 to 2025 | $1,264,269 | March 1, 2024 | February 28, 2029 | REED, ELAINE F | reporter.nih.gov |
| 7/14 APOL1 Long-term Kidney Transplantation Outcomes Network (APOLLO) Clinical Center | NIH | National Institute of Diabetes and Digestive and Kidney Diseases | 2022 to 2025 | $1,262,779 | September 25, 2017 | May 31, 2028 | POGGIO, EMILIO DANIEL | reporter.nih.gov |
| Artificial Intelligence Tool to Optimize Organ Transplantation Outcomes (Transplant-AI) | NIH | National Heart, Lung, and Blood Institute | 2024 to 2025 | $1,258,314 | February 5, 2024 | August 31, 2027 | HAVELKA, JIM | reporter.nih.gov |
| Role of Siglec-E in Regulating Alloimmunity | NIH | National Institute of Allergy and Infectious Diseases | 2021 to 2023 | $1,256,120 | April 1, 2019 | March 31, 2025 | RIELLA, LEONARDO V. | reporter.nih.gov |
| Molecular basis of adenosine transport and reuptake inhibition in human | NIH | National Institute of General Medical Sciences | 2021 to 2023 | $1,255,248 | April 1, 2020 | April 30, 2024 | LEE, SEOK-YONG | reporter.nih.gov |
| A novel approach to delivering therapeutics in heart transplantation | NIH | National Heart, Lung, and Blood Institute | 2021 to 2022 | $1,255,235 | September 1, 2019 | December 31, 2022 | ABDI, REZA | reporter.nih.gov |
| Efficacy and Mechanisms of Dapagliflozin in Promoting Kidney Function and Cardiovascular Health in Kidney Transplant Recipients | NIH | National Institute of Diabetes and Digestive and Kidney Diseases | 2024 to 2025 | $1,254,910 | December 16, 2023 | November 30, 2028 | KENDRICK, JESSICA B | reporter.nih.gov |
| Modulation of chromatin dynamics to promote transplant survival | NIH | National Institute of Allergy and Infectious Diseases | 2024 to 2025 | $1,254,850 | December 6, 2023 | October 31, 2028 | LI, XIAN CHANG | reporter.nih.gov |
| Gut microbial beta-glucuronidases as a biomarker for mycophenolic acid enterohepatic recirculation and associated toxicities | NIH | National Institute of Diabetes and Digestive and Kidney Diseases | 2024 to 2025 | $1,253,436 | March 1, 2024 | January 31, 2026 | LEE, JOHN RICHARD | reporter.nih.gov |
| Measurement of Renal Viscoelastic Properties with Ultrasound | NIH | National Institute of Diabetes and Digestive and Kidney Diseases | 2021 to 2022 | $1,231,705 | July 7, 2012 | September 30, 2025 | URBAN, MATTHEW WILLIAM | reporter.nih.gov |
| 8/14 APOL1 Long-term Kidney Transplantation Outcomes Network (APOLLO) Clinical Center | NIH | National Institute of Diabetes and Digestive and Kidney Diseases | 2022 to 2025 | $1,223,386 | September 25, 2017 | May 31, 2028 | PASTAN, STEPHEN | reporter.nih.gov |
| Impact of mammalian target of rapamycin inhibitor therapy on aging-related outcomes | NIH | National Institute on Aging | 2023 to 2025 | $1,223,110 | February 1, 2023 | November 30, 2027 | BITTERMANN, THERESE | reporter.nih.gov |
| Vascularized liver-heart on-a-chip modeling antibody-mediated rejection and tolerance of allografts | NIH | National Institute of Allergy and Infectious Diseases | 2024 to 2025 | $1,222,258 | August 14, 2024 | June 30, 2028 | JUCAUD, VADIM | reporter.nih.gov |
| Translational Dysregulation Driving Mesenchymal Cell Fibrogenic Transformation and Chronic Lung Allograft Dysfunction | NIH | National Heart, Lung, and Blood Institute | 2021 to 2023 | $1,220,895 | August 1, 2009 | April 30, 2023 | LAMA, VIBHA N | reporter.nih.gov |
| Mechanisms of action, optimization and application of Bregs | NIH | National Institute of Allergy and Infectious Diseases | 2024 to 2025 | $1,219,887 | January 1, 2006 | December 31, 2027 | MARKMANN, JAMES FRANCIS | reporter.nih.gov |
| Improving transplant organ survival through the mitigation of donor-derived mitochondrial damage-associated molecular patterns | NIH | National Institute of Allergy and Infectious Diseases | 2021 to 2023 | $1,214,149 | August 17, 2020 | July 31, 2025 | POLLARA, JUSTIN JOSEPH | reporter.nih.gov |
| 2/4-American Consortium of Early Liver Transplantation-Prospective Alcohol-associated liver disease Cohort Evaluation (ACCELERATE-PACE) | NIH | National Institute on Alcohol Abuse and Alcoholism | 2023 to 2025 | $1,205,015 | August 17, 2023 | July 31, 2030 | SERPER, MARINA | reporter.nih.gov |
| 4/14 APOL1 Long-term Kidney Transplantation Outcomes Network (APOLLO) Clinical Center | NIH | National Institute of Diabetes and Digestive and Kidney Diseases | 2022 to 2025 | $1,202,677 | September 25, 2017 | May 31, 2028 | AGARWAL, GAURAV | reporter.nih.gov |
| Immunoengineering of donor lungs to optimize long-term graft function | NIH | National Institute of Allergy and Infectious Diseases | 2024 to 2025 | $1,190,652 | February 12, 2024 | December 31, 2028 | KESHAVJEE, SHAF | reporter.nih.gov |
| 3/4-The INTEGRATE Study: Evaluating INTEGRATEd Care to Improve Biopsychosocial Outcomes of Early Liver Transplantation for Alcohol-Associated Liver Disease | NIH | National Institute on Alcohol Abuse and Alcoholism | 2023 to 2025 | $1,185,356 | August 10, 2023 | July 31, 2030 | GOLDBERG, DAVID SETH | reporter.nih.gov |
| 1-13 ApoL1 Genotypes in Kidney Donors and Long-Term Outcomes in Kidney Transplant Recipients Clinical Center | NIH | National Institute of Diabetes and Digestive and Kidney Diseases | 2022 to 2025 | $1,177,436 | September 25, 2017 | May 31, 2028 | FORNONI, ALESSIA | reporter.nih.gov |
| Clinical and Molecular Biomarkers of Endpoints in Pediatric Renal Transplantation | NIH | National Institute of Diabetes and Digestive and Kidney Diseases | 2021 to 2024 | $1,176,120 | September 15, 2020 | August 31, 2025 | SEIFERT, MICHAEL EDWARD | reporter.nih.gov |
| Innate Immune Regulation by HSF1 in Liver Inflammatory Injury | NIH | National Institute of Allergy and Infectious Diseases | 2021 to 2023 | $1,170,000 | January 25, 2019 | June 30, 2024 | KE, BIBO | reporter.nih.gov |
| Targeting POGLUT1 to promote biliary development in Alagille syndrome | NIH | National Institute of Diabetes and Digestive and Kidney Diseases | 2022 to 2024 | $1,169,691 | September 1, 2022 | July 31, 2025 | JAFAR-NEJAD, HAMED | reporter.nih.gov |
| Understanding the immune response changes to clinical interventions for Epstein-Barr virus infection prior to lymphoma development in children after organ transplants (UNEARTH) | NIH | National Cancer Institute | 2023 to 2024 | $1,169,589 | September 1, 2023 | October 1, 2024 | DHARNIDHARKA, VIKAS R. | reporter.nih.gov |
| Non-invasive Monitoring for Infections and Rejection after Lung Transplantation | NIH | National Institute of Allergy and Infectious Diseases | 2024 to 2025 | $1,167,634 | June 20, 2024 | May 31, 2029 | BOLLYKY, PAUL L | reporter.nih.gov |
| 3/4-American Consortium of Early Liver Transplantation-Prospective Alcohol-associated liver disease Cohort Evaluation (ACCELERATE-PACE) | NIH | National Institute on Alcohol Abuse and Alcoholism | 2023 to 2025 | $1,166,224 | August 17, 2023 | July 31, 2030 | LUCEY, MICHAEL RONAN | reporter.nih.gov |
| Immunological and functional consequences triggered by the gut microbiota regulate alloimmunity and cardiac transplant outcome | NIH | National Heart, Lung, and Blood Institute | 2021 to 2022 | $1,157,468 | July 15, 2019 | June 30, 2024 | BROMBERG, JONATHAN S | reporter.nih.gov |
| Tertiary Lymphoid Organs in Transplantation | NIH | National Institute of Allergy and Infectious Diseases | 2021 to 2023 | $1,156,800 | May 17, 2019 | April 30, 2024 | OBERBARNSCHEIDT, MARTIN H | reporter.nih.gov |
| Dichotomous roles of Shroom3 in Tubular cells and Podocytes in native and allograft kidneys | NIH | National Institute of Diabetes and Digestive and Kidney Diseases | 2021 to 2023 | $1,130,625 | September 10, 2019 | July 31, 2025 | MENON, MADHAV C | reporter.nih.gov |
| 4/4-American Consortium of Early Liver Transplantation-Prospective Alcohol-associated liver disease Cohort Evaluation (ACCELERATE-PACE) | NIH | National Institute on Alcohol Abuse and Alcoholism | 2023 to 2025 | $1,116,244 | August 1, 2023 | July 31, 2030 | GHOBRIAL, RAFIK MARK | reporter.nih.gov |
| Immunobiology of Alloimmunization by Platelet Transfusion | NIH | National Heart, Lung, and Blood Institute | 2021 to 2022 | $1,101,172 | August 15, 2019 | June 30, 2024 | ZIMRING, JAMES C. | reporter.nih.gov |
| Deconstructing B cell transplantation tolerance | NIH | National Institute of Allergy and Infectious Diseases | 2021 to 2022 | $1,098,684 | August 1, 2019 | July 31, 2024 | CHONG, ANITA S | reporter.nih.gov |
| Genetics and Immune Predictors for Recurrent Glomerular Diseases in the Kidney Allograft | NIH | National Institute of Diabetes and Digestive and Kidney Diseases | 2023 to 2025 | $1,096,846 | April 1, 2023 | January 31, 2028 | BATAL, IBRAHIM | reporter.nih.gov |
| Monocyte and Macrophage Functional Evolution in Kidney Transplantation | NIH | National Institute of Diabetes and Digestive and Kidney Diseases | 2024 to 2025 | $1,091,998 | September 5, 2024 | June 30, 2029 | LUO, XUNRONG | reporter.nih.gov |
| Methods for the Analysis of Event Processes Arising in Organ Transplantation | NIH | National Institute of Diabetes and Digestive and Kidney Diseases | 2021 to 2025 | $1,091,924 | September 15, 2005 | July 31, 2029 | SCHAUBEL, DOUGLAS EARL | reporter.nih.gov |
| Anti-Mullerian hormone for preserving ovarian function before administration of gonadotoxic therapies or after transplantation of cryopreserved tissue. | NIH | Eunice Kennedy Shriver National Institute of Child Health & Human Development | 2023 to 2025 | $1,089,631 | August 8, 2023 | April 30, 2028 | JAMES, DAYLON J | reporter.nih.gov |
| Impact of ableism and state laws designed to mitigate ableism on organ transplant equity for kidney transplant candidates with intellectual or developmental disabilities | NIH | Eunice Kennedy Shriver National Institute of Child Health & Human Development | 2024 to 2025 | $1,086,196 | August 1, 2024 | June 30, 2029 | HAND, BRITTANY NICOLE | reporter.nih.gov |
| 3/14 ApoL1 Long-Term Kidney Transplantation Outcomes Network (Apollo) Clinical Center | NIH | National Institute of Diabetes and Digestive and Kidney Diseases | 2022 to 2025 | $1,081,955 | September 25, 2017 | May 31, 2028 | BRENNAN, DANIEL CONLON | reporter.nih.gov |
| 1/2 Circulatory Support in Pediatric Heart Failure Patients Using the Jarvik 2015 LVAD: A Pivotal Trial | NIH | National Heart, Lung, and Blood Institute | 2024 | $1,073,956 | February 1, 2024 | January 31, 2026 | ALMOND, CHRISTOPHER | reporter.nih.gov |
| Long-term Kidney Transplantation Outcomes Network (APOLLO) Clinical Center | NIH | National Institute of Diabetes and Digestive and Kidney Diseases | 2022 to 2025 | $1,071,845 | September 25, 2017 | May 31, 2028 | BIRDWELL, KELLY A | reporter.nih.gov |
| Origin and Life Cycle of the Uterine Natural Killer Cell: Novel Insights from Human Uterus Transplantation | NIH | National Institute of Allergy and Infectious Diseases | 2021 to 2023 | $1,069,762 | September 10, 2019 | August 31, 2024 | O'NEILL, KATHLEEN ELISE | reporter.nih.gov |
| Immunologic Biomarkers of Rejection in Clinical Liver Transplantation | NIH | National Cancer Institute | 2021 to 2024 | $1,067,480 | June 1, 2020 | May 31, 2026 | EMAMAULLEE, JULIET | reporter.nih.gov |
| Modulating endothelial cell immunometabolism and mitochondrial morphologyimplications for organ transplantation | NIH | National Institute of Allergy and Infectious Diseases | 2022 to 2023 | $1,061,984 | June 12, 2019 | November 30, 2024 | NADIG, SATISH N | reporter.nih.gov |
| 2/2 Circulatory Support in Pediatric Heart Failure Patients Using the Jarvik 2015 LVAD: A Pivotal Trial | NIH | National Heart, Lung, and Blood Institute | 2024 | $1,061,181 | February 1, 2024 | January 31, 2030 | MAGNAVITA, ASHLEY | reporter.nih.gov |
| Improved early prognostic algorithm for hepatocellulcar carcinoma | NIH | National Cancer Institute | 2021 to 2024 | $1,047,183 | April 1, 2020 | June 30, 2025 | KIM, AMY K | reporter.nih.gov |
| Characterization of microvasculature in kidney transplant by super-resolution ultrasound imaging | NIH | National Institute of Diabetes and Digestive and Kidney Diseases | 2024 to 2025 | $1,044,664 | May 9, 2024 | March 31, 2029 | HUANG, CHENGWU | reporter.nih.gov |
| Defining Phenotypes of Alcohol-Associated Liver Disease with Acute Hepatic Decompensation | NIH | National Institute on Alcohol Abuse and Alcoholism | 2021 to 2025 | $1,043,280 | June 10, 2021 | May 31, 2026 | KWONG, ALLISON | reporter.nih.gov |
| Novel mechanisms of age-enhanced vasculopathy after heart transplantation | NIH | National Institute of Allergy and Infectious Diseases | 2021 to 2022 | $1,039,669 | February 5, 2018 | January 31, 2024 | GOLDSTEIN, DANIEL ROBERT | reporter.nih.gov |
| Evaluation of Angiopoietins as Prognostic Markers of Kidney Allograft Structure and Function | NIH | National Institute of Diabetes and Digestive and Kidney Diseases | 2021 to 2025 | $1,035,280 | September 15, 2021 | May 31, 2027 | MANSOUR, SHERRY GEORGE | reporter.nih.gov |
| Clinically Relevant Pharmacologic and Immunomodulatory Strategies to Achieve Long-term Survival of Kidney Xenografts in Primates | NIH | National Institute of Allergy and Infectious Diseases | 2025 | $1,031,754 | September 2, 2025 | August 31, 2030 | YAMADA, KAZUHIKO | reporter.nih.gov |
| 13/14 APOL1 Long-term Kidney Transplantation Outcomes Network (APOLLO) Clinical Center | NIH | National Institute of Diabetes and Digestive and Kidney Diseases | 2022 to 2025 | $1,003,340 | September 25, 2017 | May 31, 2028 | REEVES-DANIEL, AMBER | reporter.nih.gov |
| Human Vertebral Body Mesenchymal Stromal Cells from Organ Donors For Limb Preservation in a Murine Model of Diabetic Hindlimb Ischemia | NIH | National Heart, Lung, and Blood Institute | 2024 to 2025 | $988,439 | January 5, 2024 | November 30, 2027 | MURPHY, MICHAEL PATRICK | reporter.nih.gov |
| Defining the relationship between host-microbiome interactions and rejection after intestinal transplantation | NIH | National Institute of Allergy and Infectious Diseases | 2021 to 2025 | $962,280 | May 17, 2021 | April 30, 2026 | WEINER, JOSHUA | reporter.nih.gov |
| Defining the molecular landscape of hyperfiltration-mediated glomerular injury using kidney allografts as a model system | NIH | National Institute of Diabetes and Digestive and Kidney Diseases | 2021 to 2025 | $962,027 | April 1, 2021 | October 31, 2026 | NAIK, ABHIJIT S | reporter.nih.gov |
| 5/14 APOL1 Long-term Kidney Transplantation Outcomes Network (APOLLO) Clinical Center | NIH | National Institute of Diabetes and Digestive and Kidney Diseases | 2022 to 2025 | $949,846 | September 25, 2017 | May 31, 2028 | MOHAN, SUMIT | reporter.nih.gov |
| Leveraging Technology to Improve Medication Adherence in Adolescent and Young Adult Kidney or Liver Transplant Recipients | NIH | National Institute of Diabetes and Digestive and Kidney Diseases | 2021 to 2025 | $949,764 | September 15, 2021 | May 31, 2027 | EATON, CYD KUMIKO | reporter.nih.gov |
| CMV and CMV-Immune Responses in Geriatric Conditions Post-Kidney Transplant (CMV-GeriKT) | NIH | National Institute on Aging | 2021 to 2025 | $944,080 | August 15, 2021 | May 31, 2025 | ABIDI, MAHEEN ZEHRA | reporter.nih.gov |
| MHC and KIR Sequencing and Association Analyses in the iGeneTRAiN Studies | NIH | National Institute of Allergy and Infectious Diseases | 2021 to 2022 | $920,178 | September 2, 2020 | June 30, 2025 | KEATING, BRENDAN JAMES | reporter.nih.gov |
| Optimization of LGM2605 for use as a device in lung transplant | NIH | National Heart, Lung, and Blood Institute | 2021 | $916,148 | September 1, 2018 | August 31, 2024 | SIELECKI, THAIS MOTRIA | reporter.nih.gov |
| Transforming Curiosity into Donation: Validating a Risk Prediction Index to Detect and Prevent Drop-Out in Potential Living Kidney Donors who are Racial/Ethnic Minorities | NIH | National Institute of Diabetes and Digestive and Kidney Diseases | 2023 to 2025 | $900,098 | September 1, 2023 | May 31, 2028 | WATERMAN, AMY DOGGETTE | reporter.nih.gov |
| The Gut Microbiome in Carbapenem-Resistant Enterobacteriaceae Colonization, Persistence, Infection, and Tolerance after Lung or Liver Transplantation | NIH | National Institute of Allergy and Infectious Diseases | 2021 to 2025 | $895,725 | February 22, 2021 | January 31, 2027 | HAIDAR, GHADY | reporter.nih.gov |
| Targeting Donor Regulatory Dendritic Cells During Normothermic Ex Vivo Liver Perfusion to Overcome Rejection after Liver Transplant | NIH | National Institute of Allergy and Infectious Diseases | 2021 to 2025 | $893,685 | June 7, 2021 | May 31, 2026 | AL-ADRA, DAVID PETER | reporter.nih.gov |
| An Automated Frailty Scoring System for Lung Transplantation Based on Bio-Geo-Composition | NIH | National Heart, Lung, and Blood Institute | 2024 to 2025 | $892,517 | August 15, 2024 | May 31, 2028 | PU, JIANTAO | reporter.nih.gov |
| Isochoric Pressure Based Preservation of Cells, Tissues and Organs | NIH | National Institute of Allergy and Infectious Diseases | 2021 | $890,768 | August 1, 2016 | March 31, 2024 | TAYLOR, MICHAEL JOHN | reporter.nih.gov |
| Targeted delivery of immunosuppressive agents to the graft endothelium forthe prevention of rejection in lung transplantation | NIH | National Institute of Allergy and Infectious Diseases | 2024 to 2025 | $884,368 | September 1, 2022 | June 30, 2027 | ATKINSON, CARL | reporter.nih.gov |
| 6/14 APOL1 Long-term Kidney Transplantation Outcomes Network (APOLLO) Clinical Center | NIH | National Institute of Diabetes and Digestive and Kidney Diseases | 2023 to 2025 | $870,626 | November 2, 2023 | May 31, 2028 | DADHANIA, DARSHANA | reporter.nih.gov |
| Phase 2 Clinical Trial Evaluating a Novel Therapy in Patients who are Post-lung Transplant | NIH | National Heart, Lung, and Blood Institute | 2021 | $870,601 | July 1, 2020 | June 30, 2022 | COPELAND, DANIEL W. | reporter.nih.gov |
| Understanding Long-term Outcomes of Living Kidney Donors using Real-World Evidence from National EHR Data | NIH | National Institute of Diabetes and Digestive and Kidney Diseases | 2025 | $860,513 | September 10, 2025 | August 31, 2030 | MANKOWSKI, MICHAL A | reporter.nih.gov |
| Addressing social adversity to improve outcomes among children undergoing liver transplant: the role for a health advocate on the transplant team | NIH | National Institute of Diabetes and Digestive and Kidney Diseases | 2022 to 2025 | $859,820 | June 1, 2022 | April 30, 2027 | WADHWANI, SHARAD | reporter.nih.gov |
| XFIT: An Exercise-based Frailty Intervention in Lung Transplant Candidates | NIH | National Heart, Lung, and Blood Institute | 2024 to 2025 | $856,339 | September 17, 2024 | July 31, 2026 | SINGER, JONATHAN PAUL | reporter.nih.gov |
| Critical Role for Microvasculature in Airway Transplantation | NIH | National Heart, Lung, and Blood Institute | 2021 to 2022 | $853,870 | April 1, 2010 | May 31, 2025 | NICOLLS, MARK ROBERT | reporter.nih.gov |
| The novel role of MIF-CD74 inflammatory pathway in immune regulation | NIH | National Institute of Allergy and Infectious Diseases | 2024 to 2025 | $848,445 | December 1, 2023 | October 31, 2028 | AZZI, JAMIL | reporter.nih.gov |
| Myeloid Specific Targeted Nanoimunotherapy for Organ Transplant Acceptance | NIH | National Institute of Allergy and Infectious Diseases | 2021 to 2022 | $847,500 | May 25, 2018 | April 30, 2023 | OCHANDO, JORDI | reporter.nih.gov |
| Interferon-beta in transplant | NIH | National Institute of Allergy and Infectious Diseases | 2021 to 2022 | $847,500 | September 24, 2018 | August 31, 2023 | FRIBOURG, MIGUEL | reporter.nih.gov |
| Individualized immunosuppression in organ transplant recipients based on real world evidence and artificial intelligence | NIH | National Institute of Diabetes and Digestive and Kidney Diseases | 2025 | $847,371 | September 15, 2025 | July 31, 2030 | BAE, SUNJAE | reporter.nih.gov |
| The Landscape of Serious Infections following Kidney Transplantation in People Living with HIV | NIH | National Institute of Allergy and Infectious Diseases | 2021 to 2025 | $846,608 | August 19, 2021 | July 31, 2026 | WERBEL, WILLIAM | reporter.nih.gov |
| Multi-omic Biomarker Discovery and Validation in Heart Transplant Patient Populations | NIH | National Institute of Allergy and Infectious Diseases | 2024 | $845,245 | March 1, 2020 | February 28, 2026 | KEATING, BRENDAN JAMES | reporter.nih.gov |
| Designing ABO-Compatible US Kidney Allocation - Resubmission - 1 | NIH | National Institute of Diabetes and Digestive and Kidney Diseases | 2025 | $843,457 | September 15, 2025 | June 30, 2030 | MANKOWSKI, MICHAL A | reporter.nih.gov |
| TNFRSF13B polymorphisms and immunity to transplantation | NIH | National Institute of Allergy and Infectious Diseases | 2023 to 2024 | $842,839 | August 15, 2023 | October 31, 2024 | CASCALHO, MARILIA ISABEL | reporter.nih.gov |
| Developing the Optimal Prehabilitation Program for Kidney Transplant Candidates on Hemodialysis - Resubmission - 1 | NIH | National Institute of Diabetes and Digestive and Kidney Diseases | 2025 | $842,633 | September 24, 2025 | July 31, 2030 | ORANDI, BABAK JOHN | reporter.nih.gov |
| Microbial biomarkers of intestinal MDR colonization after solid organ transplantation | NIH | National Institute of Allergy and Infectious Diseases | 2025 | $841,520 | December 2, 2024 | November 30, 2029 | UHLEMANN, ANNE-CATRIN | reporter.nih.gov |
| Impact of Geographic Boundaries on Deceased Donor Kidney Discard, Allocation, and Outcomes | NIH | National Institute of Diabetes and Digestive and Kidney Diseases | 2021 to 2025 | $837,981 | September 2, 2021 | July 31, 2026 | POTLURI, VISHNU SAGAR | reporter.nih.gov |
| Innate Recognition of Allogeneic Non-Self | NIH | National Institute of Allergy and Infectious Diseases | 2021 to 2022 | $836,918 | September 27, 2012 | May 31, 2025 | LAKKIS, FADI G. | reporter.nih.gov |
| Advanced body composition imaging to improve outcomes in lung transplantation | NIH | National Heart, Lung, and Blood Institute | 2025 | $833,388 | August 25, 2025 | April 30, 2030 | ANDERSON, MICHAELA RESTIVO | reporter.nih.gov |
| Immune signatures of CMV disease risk after orthotopic liver transplant | NIH | National Institute of Allergy and Infectious Diseases | 2025 | $832,910 | May 9, 2025 | April 30, 2030 | FORD, EMILY | reporter.nih.gov |
| Transplanting Lungs from Uncontrolled Donation after Circulatory Death | NIH | National Heart, Lung, and Blood Institute | 2022 to 2023 | $830,782 | July 8, 2022 | June 30, 2024 | WALL, STEPHEN P | reporter.nih.gov |
| Targeted delivery of immunosuppressive agents to the graft endothelium for the prevention of rejection in lung transplantation | NIH | National Institute of Allergy and Infectious Diseases | 2022 to 2023 | $823,831 | September 1, 2022 | April 30, 2024 | ATKINSON, CARL | reporter.nih.gov |
| Molecular mismatch as a marker for immunologic risk in heart transplant recipients | NIH | National Heart, Lung, and Blood Institute | 2025 | $819,532 | June 25, 2025 | March 31, 2030 | LONZE, BONNIE ELIZABETH | reporter.nih.gov |
| Biopsychosocial Risk Factors for Psychiatric Disorders Following Kidney Transplantation | NIH | National Institute of Mental Health | 2022 to 2025 | $810,384 | August 1, 2022 | July 31, 2027 | NASH, REBEKAH POTTS | reporter.nih.gov |
| Patient provider communication and disparities in access to home dialysis and kidney transplantation | NIH | National Institute of Diabetes and Digestive and Kidney Diseases | 2025 | $810,330 | September 4, 2025 | June 30, 2030 | KU, ELAINE | reporter.nih.gov |
| Achieving Clinically Relevant Tolerance in NHP Heart Allograft Recipients | NIH | National Institute of Allergy and Infectious Diseases | 2021 | $808,124 | March 17, 2021 | July 12, 2021 | MADSEN, JOREN C | reporter.nih.gov |
| T cell fate decisions and transplant outcomes | NIH | National Institute of Allergy and Infectious Diseases | 2021 to 2022 | $807,500 | January 10, 2018 | December 31, 2023 | LI, XIAN CHANG | reporter.nih.gov |
| IRF4-dependent T-cell effector programs in governing transplant outcomes | NIH | National Institute of Allergy and Infectious Diseases | 2021 to 2022 | $807,500 | May 1, 2018 | January 11, 2024 | CHEN, WENHAO | reporter.nih.gov |
| Geographic Variation in Non-HCC MELD Exceptions and Its Effect on Liver Transplant Waitlist Outcomes | NIH | National Institute of Diabetes and Digestive and Kidney Diseases | 2021 to 2025 | $806,993 | June 1, 2021 | March 31, 2026 | CANNON, ROBERT M. | reporter.nih.gov |
| Phenotyping Net Immune State with MicroRNAs in Cardiac Transplantation | NIH | National Heart, Lung, and Blood Institute | 2025 | $804,438 | March 4, 2025 | January 31, 2030 | SHAH, PALAK | reporter.nih.gov |
| Innovative approaches to enhance regulatory myeloid cell function and renal transplant survival in nonhuman primates | NIH | National Institute of Allergy and Infectious Diseases | 2024 | $804,385 | June 7, 2024 | April 30, 2025 | THOMSON, ANGUS W | reporter.nih.gov |
| Protective role of Honokiol in preventing c-Met-induced post-transplantation cancer | NIH | National Cancer Institute | 2021 to 2022 | $801,678 | June 1, 2018 | May 31, 2025 | PAL, SOUMITRO | reporter.nih.gov |
| Tailored siRNA delivery to human endothelium to inhibit and reverse inflammatory damage following ischemia reperfusion injury in the kidney | NIH | National Heart, Lung, and Blood Institute | 2022 to 2024 | $800,484 | September 1, 2022 | August 31, 2025 | BRACAGLIA, LAURA | reporter.nih.gov |
| Prospective Investigation of Cirrhotic Cardiomyopathy in Humans | NIH | National Heart, Lung, and Blood Institute | 2025 | $799,287 | September 16, 2025 | June 30, 2030 | IZZY, MANHAL JABER | reporter.nih.gov |
| Prognostic Significance of microRNA Expression in Children with Cardiomyopathy | NIH | National Heart, Lung, and Blood Institute | 2021 | $799,064 | February 17, 2018 | January 31, 2024 | LIPSHULTZ, STEVEN EDWARD | reporter.nih.gov |
| Pathological activation of integrated stress response as a driver of Chronic allograft dysfunction after lung transplant | NIH | National Heart, Lung, and Blood Institute | 2025 | $798,958 | January 1, 2025 | November 30, 2029 | KURIHARA, CHITARU | reporter.nih.gov |
| Candidate Selection for Liver Transplantation in Patients with Alcohol-related Liver Disease | NIH | National Institute on Alcohol Abuse and Alcoholism | 2021 to 2024 | $792,720 | July 1, 2020 | June 30, 2026 | CHEN, PO-HUNG (VICTOR) | reporter.nih.gov |
| Engineering an Oxygen-Carrying Perfusate for Normothermic Machine Lung Perfusion | NIH | National Heart, Lung, and Blood Institute | 2025 | $784,227 | July 15, 2025 | April 30, 2029 | PALMER, ANDRE FRANCIS | reporter.nih.gov |
| Incorporating Donor Lung CT Images into Machine Learning Models to Predict Severe Primary Graft Dysfunction after Lung Transplantation | NIH | National Heart, Lung, and Blood Institute | 2025 | $782,289 | August 15, 2025 | May 31, 2029 | HACHEM, RAMSEY | reporter.nih.gov |
| Virtual coaching for potential kidney transplant candidates and their social support networks | NIH | National Institute of Diabetes and Digestive and Kidney Diseases | 2023 to 2025 | $779,249 | March 15, 2023 | January 31, 2027 | HART, ALLYSON | reporter.nih.gov |
| Shared decision making for kidney transplant candidates to plan for an organ offer decision | NIH | National Institute of Diabetes and Digestive and Kidney Diseases | 2023 to 2025 | $777,072 | December 15, 2022 | November 30, 2026 | SCHAFFHAUSEN, CORY R | reporter.nih.gov |
| Development of synthetic heparin to protect liver graft from ischemia reperfusion injury during transplantation | NIH | National Cancer Institute | 2025 | $775,669 | July 1, 2023 | August 31, 2028 | ARNOLD, KATELYN | reporter.nih.gov |
| A Deep Learning Model to Improve Pathologist Interpretation of Donor Kidney Biopsies | NIH | National Institute of Diabetes and Digestive and Kidney Diseases | 2021 | $775,114 | September 21, 2018 | August 31, 2023 | GAUT, JOSEPH P | reporter.nih.gov |
| Identifying Behavioral Factors Contributing to High Discard Rate of Deceased Donor Kidneys | NIH | National Institute of Diabetes and Digestive and Kidney Diseases | 2024 to 2025 | $772,937 | March 15, 2024 | January 31, 2028 | GREEN, ELLEN P | reporter.nih.gov |
| 4/4: The INTEGRATE Study: Evaluating INTEGRATEd care to Improve Biopsychosocial Outcomes of Early Liver Transplant for Alcohol-Associated Liver Disease | NIH | National Institute on Alcohol Abuse and Alcoholism | 2024 to 2025 | $769,691 | August 16, 2023 | July 31, 2030 | MELLINGER, JESSICA LEIGH | reporter.nih.gov |
| Targeting Fibroblast Growth Factor Receptor-2b in prevention and treatment of cutaneous Squamous cell carcinoma. | NIH | National Cancer Institute | 2021 to 2022 | $769,642 | January 15, 2018 | December 31, 2024 | NATHAN, CHERIE-ANN O | reporter.nih.gov |
| Role of Tregs in the acquisition and maintenance of Tconv anergy in transplantation tolerance | NIH | National Institute of Allergy and Infectious Diseases | 2025 | $766,265 | July 23, 2025 | June 30, 2030 | ALEGRE, MARIA-LUISA | reporter.nih.gov |
| Assessing Multi-level Barriers to Living Liver Donor Transplantation | NIH | National Institute of Diabetes and Digestive and Kidney Diseases | 2023 to 2025 | $762,597 | September 1, 2023 | May 31, 2028 | GORDON, ELISA J | reporter.nih.gov |
| Functional significance of plasma cell infiltrates of human cardiac allograft vasculopathy | NIH | National Institute of Allergy and Infectious Diseases | 2025 | $761,840 | August 5, 2025 | July 31, 2030 | ZORN, EMMANUEL | reporter.nih.gov |
| Improving lung transplant outcomes through the use of imaging in a DBD rat model | NIH | National Heart, Lung, and Blood Institute | 2021 | $759,350 | August 15, 2018 | June 30, 2025 | RIZI, RAHIM R | reporter.nih.gov |
| Development of a liver viability index for transplantation | NIH | National Institute of Diabetes and Digestive and Kidney Diseases | 2021 to 2022 | $758,250 | August 1, 2012 | June 30, 2024 | UYGUN, KORKUT | reporter.nih.gov |
| Defining optimal tacrolimus dosing and concentrations in the early post-lung transplant period based on short- and long-term clinical impacts | NIH | National Heart, Lung, and Blood Institute | 2022 | $756,480 | September 16, 2022 | February 28, 2025 | SHASHATY, MICHAEL G. S. | reporter.nih.gov |
| Liver Xenotransplantation using CRISPR-modified Porcine Organs | NIH | National Institute of Allergy and Infectious Diseases | 2024 | $754,875 | February 1, 2020 | January 31, 2026 | MARKMANN, JAMES FRANCIS | reporter.nih.gov |
| Lymphatic Dysfunction and Development of Post-Transplant Obliterative Bronchiolitis | NIH | National Heart, Lung, and Blood Institute | 2025 | $750,162 | January 1, 2025 | November 30, 2028 | HANCOCK, WAYNE WILLIAM | reporter.nih.gov |
| The novel role of the immunoproteasome subunit LMP7 in allo-immunity and T cell exhaustion | NIH | National Institute of Allergy and Infectious Diseases | 2021 to 2022 | $747,619 | December 18, 2017 | November 30, 2022 | AZZI, JAMIL | reporter.nih.gov |
| Whole heart suspended animation: leveraging the zebrafish to solve the organ shortage | NIH | National Heart, Lung, and Blood Institute | 2021 to 2023 | $747,000 | April 1, 2021 | March 31, 2024 | TESSIER, SHANNON NOELLA | reporter.nih.gov |
| Fibrinolysis Dysfunction Impact on Graft Function in Liver Transplantation | NIH | National Heart, Lung, and Blood Institute | 2021 to 2023 | $746,997 | September 1, 2021 | August 31, 2024 | MOORE, HUNTER B | reporter.nih.gov |
| Strengthening Shared Decision-Making for Older Adults with Kidney Failure Considering Kidney Transplant | NIH | National Institute of Diabetes and Digestive and Kidney Diseases | 2022 to 2025 | $744,620 | April 15, 2022 | February 28, 2027 | BUTLER, CATHERINE R | reporter.nih.gov |
| MicroRNA Biomarkers of Allograft Rejection and Cardiac Allograft Vasculopathy in Cardiac Transplantation | NIH | National Heart, Lung, and Blood Institute | 2021 to 2024 | $740,880 | July 1, 2020 | June 30, 2025 | SHAH, PALAK | reporter.nih.gov |
| Epigenetic regulation of donor heart preservation mediated by Brd4 | NIH | National Heart, Lung, and Blood Institute | 2025 | $739,562 | August 15, 2025 | May 31, 2029 | LEI, IENG LAM | reporter.nih.gov |
| Novel assay to monitor Tacrolimus levels at the point of care | NIH | National Institute of Allergy and Infectious Diseases | 2021 | $735,018 | June 15, 2018 | July 31, 2023 | DARBY, MARTYN | reporter.nih.gov |
| Development and Evaluation of a Mobile Directly Observed Therapy Smartphone App for Immunosuppressive Adherence in Transplant Patients | NIH | National Institute of Diabetes and Digestive and Kidney Diseases | 2021 | $728,484 | September 19, 2019 | August 31, 2023 | SEIGUER, SEBASTIAN | reporter.nih.gov |
| Epigenetic Regulation of Regulatory B Cell Cytokine Expression and Allograft Rejection | NIH | National Institute of Allergy and Infectious Diseases | 2022 to 2025 | $727,129 | December 17, 2021 | November 30, 2026 | CHERUKURI, ARAVIND | reporter.nih.gov |
| Tolerance to Allogeneic Hearts via Implantation of Cultured Donor Thymus | NIH | National Heart, Lung, and Blood Institute | 2025 | $725,892 | January 1, 2025 | November 30, 2028 | TUREK, JOSEPH | reporter.nih.gov |
| Novel Anti-HCMV Strategies | NIH | National Heart, Lung, and Blood Institute | 2021 | $722,643 | April 15, 2018 | March 31, 2023 | CHAN, GARY CHING TAO | reporter.nih.gov |
| Developing personalized immunosuppression for older kidney transplant recipients | NIH | National Institute of Diabetes and Digestive and Kidney Diseases | 2021 to 2022 | $719,688 | December 18, 2018 | February 14, 2022 | MCADAMS DEMARCO, MARA A. | reporter.nih.gov |
| IMPAKT Study: Imaging Modalities in Pediatric Assessments of Kidney Transplants | NIH | National Institute of Diabetes and Digestive and Kidney Diseases | 2022 to 2025 | $718,233 | July 15, 2022 | March 31, 2027 | VITERI BAQUERIZO, BERNARDA | reporter.nih.gov |
| THE VIROME AND ADVERSE OUTCOMES IN LUNG TRANSPLANTATION | NIH | National Heart, Lung, and Blood Institute | 2021 | $713,714 | May 1, 2017 | April 30, 2024 | WANG, DAVID | reporter.nih.gov |
| 9/14 APOL1 Long-term Kidney Transplantation Outcomes Network (APOLLO) Clinical Center | NIH | National Institute of Diabetes and Digestive and Kidney Diseases | 2023 to 2025 | $711,381 | September 25, 2017 | May 31, 2028 | ROSAS, SYLVIA E | reporter.nih.gov |
| Ex Vivo Storage, Preservation And Rehabilitation Of Living Heart Valves For Allogenic Valve Transplantation | NIH | National Heart, Lung, and Blood Institute | 2025 | $709,718 | September 1, 2025 | May 31, 2030 | KALFA, DAVID | reporter.nih.gov |
| Telemedicine for Evaluation and Counseling of Living Kidney Donor Candidates | NIH | National Institute of Diabetes and Digestive and Kidney Diseases | 2022 to 2025 | $706,133 | August 15, 2021 | May 31, 2027 | AL AMMARY, FAWAZ | reporter.nih.gov |
| Organ donor circadian clocks in transplantation acceptance | NIH | National Heart, Lung, and Blood Institute | 2025 | $705,421 | December 16, 2024 | November 30, 2028 | HASPEL, JEFFREY ADAM | reporter.nih.gov |
| Personalized Risk Prediction and Mechanistic Profiling of Cardiac Allograft Vasculopathy | NIH | National Heart, Lung, and Blood Institute | 2025 | $705,063 | August 15, 2025 | May 31, 2029 | PEYSTER, ELIOT | reporter.nih.gov |
| Glycogen Synthase Kinase 3 beta in liver ischemia reperfusion injury | NIH | National Institute of Diabetes and Digestive and Kidney Diseases | 2021 to 2022 | $702,000 | May 1, 2020 | February 28, 2023 | ZHAI, YUAN | reporter.nih.gov |
| Frailty and patient centered outcomes in candidates for lung transplantation | NIH | National Heart, Lung, and Blood Institute | 2021 | $694,679 | July 1, 2017 | June 30, 2023 | SINGER, JONATHAN PAUL | reporter.nih.gov |
| Improving the liver transplant evaluation process: a data science-focused and team-based approach | NIH | National Institute of Diabetes and Digestive and Kidney Diseases | 2022 to 2025 | $691,524 | August 15, 2022 | May 31, 2027 | STRAUSS, ALEXANDRA TERESA | reporter.nih.gov |
| Targeting Immune-Responsive Gene 1 (Irg1) and Itaconate for Cardioprotection of the Donor Heart for Transplantation | NIH | National Heart, Lung, and Blood Institute | 2022 | $690,954 | July 1, 2022 | June 30, 2023 | TANG, PAUL | reporter.nih.gov |
| Engineering a Novel Bio-Scaffold for Hepatic Tissue Restoration and Drug Screening | NIH | National Institute of General Medical Sciences | 2022 to 2025 | $690,005 | June 1, 2022 | April 30, 2027 | ALI, JAMEL | reporter.nih.gov |
| A clinical decision support tool to understand the survival benefit of kidney transplantation in candidates with a history of cancer | NIH | National Institute of Diabetes and Digestive and Kidney Diseases | 2024 to 2025 | $686,973 | September 5, 2024 | July 31, 2029 | HART, ALLYSON | reporter.nih.gov |
| Perioperative and long-term risks following nephrectomy in older live kidney donors | NIH | National Institute on Aging | 2021 to 2024 | $684,480 | April 1, 2020 | December 31, 2024 | MUZAALE, ABIMEREKI D | reporter.nih.gov |
| Targeting Mineralocorticoid Receptor Condensates to Optimize Donor Heart Preservation | NIH | National Heart, Lung, and Blood Institute | 2023 | $682,912 | December 15, 2022 | July 31, 2023 | TANG, PAUL | reporter.nih.gov |
| U Maryland Mid-Atlantic APOLLO Research Network Omic and Clinical Center | NIH | National Institute of Diabetes and Digestive and Kidney Diseases | 2022 to 2025 | $681,691 | September 25, 2017 | May 31, 2028 | BROMBERG, JONATHAN S | reporter.nih.gov |
| Identifying Novel Diagnostics and Mechanisms for Cardiac Allograft Vasculopathy | NIH | National Heart, Lung, and Blood Institute | 2021 to 2024 | $681,499 | April 15, 2020 | March 31, 2026 | CLERKIN, KEVIN J | reporter.nih.gov |
| Dynamic Prediction of Renal Failure Using Longitudinal Prognostic Information among Patients with Chronic Kidney Disease and Kidney Transplant | NIH | National Institute of Diabetes and Digestive and Kidney Diseases | 2021 to 2022 | $681,111 | April 10, 2019 | March 31, 2024 | LI, LIANG | reporter.nih.gov |
| Transplantation of Discarded Livers Following Normothermic Machine Perfusion: A Multicenter RESTORE Trial | NIH | National Institute of Diabetes and Digestive and Kidney Diseases | 2023 to 2024 | $677,786 | March 15, 2023 | February 28, 2025 | CHAPMAN, WILLIAM C | reporter.nih.gov |
| Impact of tissue resident memory T cells on chronic rejection after lung transplantation | NIH | National Heart, Lung, and Blood Institute | 2021 to 2024 | $674,736 | July 1, 2020 | June 30, 2025 | SNYDER, MARK EUGENE | reporter.nih.gov |
| The Development of a Biatrial Catheter for a Cardiopulmonary Support System in Pulmonary Arterial Hypertension | NIH | National Heart, Lung, and Blood Institute | 2024 to 2025 | $671,968 | September 15, 2023 | July 31, 2026 | BENZA, RAYMOND LOUIS | reporter.nih.gov |
| Choosing Immune Suppression in Renal Transplantation by Efficacy and Morbidity2 (CISTEM2) | NIH | National Institute of Diabetes and Digestive and Kidney Diseases | 2024 | $671,504 | March 1, 2024 | January 31, 2029 | DHARNIDHARKA, VIKAS R. | reporter.nih.gov |
| Personalized Rejection Risk Assessment in Cardiac Transplantation | NIH | National Heart, Lung, and Blood Institute | 2021 to 2024 | $667,421 | September 10, 2021 | August 31, 2026 | PEYSTER, ELIOT | reporter.nih.gov |
| Precision Pharmacokinetic-Guided Tacrolimus Dosing to Improve Pediatric Heart Transplant Outcomes | NIH | National Heart, Lung, and Blood Institute | 2021 to 2024 | $667,328 | May 1, 2020 | April 30, 2025 | ROWER, JOSEPH | reporter.nih.gov |
| Allogeneic hepatocyte transplantation without immunosuppression | NIH | National Institute of Diabetes and Digestive and Kidney Diseases | 2025 | $664,769 | July 1, 2025 | April 30, 2030 | VONADA, ANNE | reporter.nih.gov |
| Veteran Access and Limitations to Organ Recovery (VALOR) | NIH | National Institute on Minority Health and Health Disparities | 2023 | $661,416 | June 10, 2022 | November 30, 2024 | LYNCH, RAYMOND J | reporter.nih.gov |
| Refining repeat screening for coronary artery disease in kidney transplant candidates | NIH | National Institute of Diabetes and Digestive and Kidney Diseases | 2021 to 2024 | $659,934 | July 1, 2020 | July 31, 2025 | CHENG, XINGXING SHELLEY | reporter.nih.gov |
| Diversity of TFH cells and DSA generation after kidney transplantation | NIH | National Institute of Allergy and Infectious Diseases | 2021 | $657,643 | March 1, 2017 | February 29, 2024 | METES, DIANA M | reporter.nih.gov |
| Improving Quality and Access to Early Steps in Kidney Transplantation | NIH | National Institute of Diabetes and Digestive and Kidney Diseases | 2021 | $656,772 | September 16, 2019 | June 30, 2023 | PATZER, RACHEL E | reporter.nih.gov |
| Clinical and molecular epidemiology of acute kidney injury after lung transplant | NIH | National Institute of Diabetes and Digestive and Kidney Diseases | 2021 | $652,060 | September 1, 2017 | January 31, 2024 | SHASHATY, MICHAEL G. S. | reporter.nih.gov |
| Phage Therapy for Recurrent UTIs in Kidney Transplant Recipients | NIH | National Institute of Diabetes and Digestive and Kidney Diseases | 2024 to 2025 | $650,235 | August 16, 2024 | June 30, 2027 | ASLAM, SAIMA | reporter.nih.gov |
| Development of a novel clinical assay for measuring everolimus levels | NIH | National Institute of Allergy and Infectious Diseases | 2021 | $648,895 | May 21, 2019 | April 30, 2023 | DARBY, MARTYN | reporter.nih.gov |
| Targeted delivery of nanomedicines to the coronary microvasculature during ex vivo normothermic perfusion of marginal human hearts | NIH | National Heart, Lung, and Blood Institute | 2022 to 2025 | $648,420 | January 1, 2022 | December 31, 2026 | STENDAHL, JOHN C | reporter.nih.gov |
| Determining Optimal Immunosuppression and Kidney Allocation Strategies for Mitigating Risks from Epstein-Barr Virus in Kidney Transplant Centers | NIH | National Institute of Allergy and Infectious Diseases | 2025 | $644,770 | May 7, 2025 | April 30, 2030 | POTLURI, VISHNU SAGAR | reporter.nih.gov |
| Functional significance of plasma cell infiltrates of human cardiac allograft vasculopathy | NIH | National Institute of Allergy and Infectious Diseases | 2024 | $642,056 | August 16, 2024 | July 31, 2025 | ZORN, EMMANUEL | reporter.nih.gov |
| CTOT: Biomarker guided CNI substitution in kidney transplantation | NIH | National Institute of Allergy and Infectious Diseases | 2021 to 2022 | $641,843 | September 15, 2004 | June 30, 2024 | HEEGER, PETER SCOTT | reporter.nih.gov |
| Developing pressure-modulated means for high-subzero liver preservation | NIH | National Institute of Diabetes and Digestive and Kidney Diseases | 2024 to 2025 | $637,977 | June 15, 2024 | April 30, 2028 | RABIN, YOED | reporter.nih.gov |
| Promoting Increases in Living Organ Donation via Tele-navigation (PILOT) | NIH | National Institute of Diabetes and Digestive and Kidney Diseases | 2025 | $631,470 | March 15, 2025 | February 28, 2027 | SEGEV, DORRY L. | reporter.nih.gov |
| TAM-Kinases in Transplant | NIH | National Heart, Lung, and Blood Institute | 2021 | $628,468 | January 15, 2018 | December 31, 2023 | THORP, EDWARD BENJAMIN | reporter.nih.gov |
| Prevention of Weight Gain and Impaired Glucose Metabolism Post Kidney Transplantation: A Pilot and Feasibility Study | NIH | National Institute of Diabetes and Digestive and Kidney Diseases | 2024 to 2025 | $620,000 | April 1, 2024 | March 31, 2027 | JAKICIC, JOHN M | reporter.nih.gov |
| Understanding the Interface of Allo and Auto-Immunity: The Impact of Angiotensin II Type 1 Receptor Antibodies in Pediatric Kidney Transplant Recipients | NIH | National Institute of Allergy and Infectious Diseases | 2021 to 2023 | $614,628 | July 1, 2019 | June 30, 2025 | PEARL, MEGHAN HALEY | reporter.nih.gov |
| VIRTUUS Children's Study: Validating Injury to the Renal Transplant Using Urinary Signatures in Children | NIH | Eunice Kennedy Shriver National Institute of Child Health & Human Development | 2021 | $613,112 | August 10, 2017 | May 31, 2024 | AMARAL, SANDRA | reporter.nih.gov |
| Targeting monocyte allorecognition to achieve allograft acceptance | NIH | National Institute of Allergy and Infectious Diseases | 2025 | $612,975 | March 10, 2025 | February 28, 2030 | OBERBARNSCHEIDT, MARTIN H | reporter.nih.gov |
| Evaluation of growth potential of ice-free vitrified heart valves in a pediatric porcine model. | NIH | National Heart, Lung, and Blood Institute | 2023 | $610,972 | April 1, 2023 | September 30, 2024 | RAJAB, TAUFIEK KONRAD | reporter.nih.gov |
| T Cell Alloreactivity and Organ Transplant Risk Stratification Models Using High-Resolution HLA and Genomic Data | NIH | National Institute of Allergy and Infectious Diseases | 2025 | $606,609 | August 1, 2025 | July 31, 2030 | MORRIS, GERALD PATRICK | reporter.nih.gov |
| Novel insights into intimal hyperplasia in cardiac allograft vasculopathy | NIH | National Heart, Lung, and Blood Institute | 2021 | $603,930 | April 1, 2018 | January 31, 2023 | MARTIN, KATHLEEN ANN | reporter.nih.gov |
| Developing a Donor-Candidate Risk Prediction System to Optimize Lung Allocation and Transplant Outcomes | NIH | National Heart, Lung, and Blood Institute | 2022 to 2025 | $598,206 | April 1, 2022 | March 31, 2027 | LEHR, CARLI JESSICA | reporter.nih.gov |
| Multi-level Factors that Influence Dialysis Facilities' Assessments of Patient Suitability for Transplantation | NIH | National Institute of Diabetes and Digestive and Kidney Diseases | 2021 to 2024 | $597,148 | April 1, 2021 | January 31, 2025 | WILK, ADAM STEVEN | reporter.nih.gov |
| Influence of Mycophenolic Acid Pharmacogenomics on Lung Transplant Outcomes | NIH | National Heart, Lung, and Blood Institute | 2021 to 2024 | $595,916 | June 1, 2021 | May 31, 2025 | TAGUE, LANESHIA K | reporter.nih.gov |
| Veteran Access and Limitations to Organ Recovery (VALOR) | NIH | National Institute on Minority Health and Health Disparities | 2022 | $584,917 | June 10, 2022 | February 28, 2023 | LYNCH, RAYMOND J | reporter.nih.gov |
| Developing personalized immunosuppression for older kidney transplant recipients | NIH | National Institute of Diabetes and Digestive and Kidney Diseases | 2022 | $584,113 | December 18, 2018 | November 30, 2024 | MCADAMS DEMARCO, MARA A. | reporter.nih.gov |
| Addressing Inactive Kidney Transplant Waitlist Status through Adapting a Tailored Psycho-Social-Environmental Program | NIH | National Institute of Diabetes and Digestive and Kidney Diseases | 2023 to 2025 | $584,051 | May 1, 2023 | January 31, 2028 | HLADEK, MELISSA | reporter.nih.gov |
| High-dimensional single-cell mapping to define immune signatures of cytomegalovirus-associated rejection in cardiac transplantation | NIH | National Heart, Lung, and Blood Institute | 2023 to 2025 | $583,740 | April 24, 2023 | March 31, 2026 | SEN, PRITHA | reporter.nih.gov |
| In vivo 2-photon imaging of retinal biochemistry before and after retinal organoid transplantation | NIH | National Eye Institute | 2023 to 2025 | $582,786 | June 1, 2023 | May 31, 2026 | BROWNE, ANDREW W | reporter.nih.gov |
| Cognitive prehabilitation to prevent Alzheimer's disease after kidney transplantation | NIH | National Institute on Aging | 2023 to 2025 | $576,522 | December 1, 2022 | November 30, 2027 | MCADAMS DEMARCO, MARA A. | reporter.nih.gov |
| Patient Oriented Research in Solid Organ Transplantation | NIH | National Institute of Allergy and Infectious Diseases | 2022 to 2024 | $573,585 | May 1, 2022 | February 28, 2025 | SEGEV, DORRY L. | reporter.nih.gov |
| The Road to Destination Therapy: Optimizing Long-Term Mechanical Cardiopulmonary Support for Pulmonary Hypertension | NIH | National Heart, Lung, and Blood Institute | 2021 | $568,633 | August 15, 2018 | June 30, 2023 | BACCHETTA, MATTHEW DOMINIC | reporter.nih.gov |
| The Impact of Frailty on Liver Transplant Outcomes in Older Adults with Hepatocellular Carcinoma | NIH | National Institute on Aging | 2023 to 2025 | $566,229 | January 15, 2023 | December 31, 2027 | LAI, JENNIFER C. | reporter.nih.gov |
| Choosing Immune Suppression in Renal Transplantation by Efficacy and Morbidity 2 (CISTEM2) | NIH | National Institute of Diabetes and Digestive and Kidney Diseases | 2025 | $561,098 | February 1, 2025 | January 31, 2029 | DHARNIDHARKA, VIKAS R. | reporter.nih.gov |
| Mending a Broken Heart Allocation System with Machine Learning | NIH | National Heart, Lung, and Blood Institute | 2021 to 2024 | $555,295 | February 1, 2020 | January 31, 2025 | PARKER, WILLIAM F | reporter.nih.gov |
| Cell Death Pathways and Heart Transplant Rejection | NIH | National Institute of Allergy and Infectious Diseases | 2021 | $550,756 | June 1, 2017 | May 31, 2022 | HEEGER, PETER SCOTT | reporter.nih.gov |
| Subzero preservation of vascular composite allografts | NIH | National Institute of Allergy and Infectious Diseases | 2022 | $546,000 | September 1, 2022 | August 31, 2024 | UYGUN, KORKUT | reporter.nih.gov |
| A Phase 1 Clinical Trial of Siltuximab for the Treatment of Antibody-Mediated Rejection after Lung Transplantation | NIH | National Heart, Lung, and Blood Institute | 2025 | $544,885 | September 15, 2023 | August 31, 2028 | HACHEM, RAMSEY | reporter.nih.gov |
| Local antibody responses in human cardiac allograft vasculopathy | NIH | National Institute of Allergy and Infectious Diseases | 2021 | $542,608 | September 8, 2021 | August 31, 2023 | ZORN, EMMANUEL | reporter.nih.gov |
| Expanding live donor kidney transplantation through advocacy training and social media | NIH | National Institute of Diabetes and Digestive and Kidney Diseases | 2021 | $534,402 | April 1, 2017 | March 31, 2023 | CAMERON, ANDREW M. | reporter.nih.gov |
| A Learning Health System to increase organ donation and promote community engagement | NIH | National Institute of Diabetes and Digestive and Kidney Diseases | 2023 to 2025 | $532,024 | September 1, 2023 | May 31, 2028 | SCHAFFHAUSEN, CORY R | reporter.nih.gov |
| Antibody responses to chemical adducts in human kidney allograft rejection | NIH | National Institute of Allergy and Infectious Diseases | 2025 | $526,658 | September 26, 2016 | November 30, 2029 | ZORN, EMMANUEL | reporter.nih.gov |
| Impact of Disparities Affecting Survival among Advanced Heart Failure Patients and Transplant Recipients | NIH | National Heart, Lung, and Blood Institute | 2021 | $526,607 | April 1, 2018 | January 31, 2023 | HSICH, EILEEN MICHELLE | reporter.nih.gov |
| Implementation of Eplet Mismatch Analysis in Pediatric Kidney Transplantation | NIH | National Institute of Diabetes and Digestive and Kidney Diseases | 2023 to 2025 | $522,724 | August 1, 2023 | May 31, 2027 | CHARNAYA, OLGA | reporter.nih.gov |
| Ex Vivo Nanoparticle Drug Delivery Targeted to Human Renal Allograft Endothelium | NIH | National Institute of Allergy and Infectious Diseases | 2021 | $518,773 | July 1, 2017 | June 30, 2023 | POBER, JORDAN S | reporter.nih.gov |
| Variations in Use of Heart Replacement Therapies Among Patients with Advanced Heart Failure | NIH | National Heart, Lung, and Blood Institute | 2021 to 2023 | $511,609 | January 15, 2019 | December 31, 2024 | KHAZANIE, PRATEETI | reporter.nih.gov |
| Lung Transplant Go (LTGO): Improving Self-Management of Exercise After Lung Transplantation | NIH | National Institute of Nursing Research | 2021 | $510,990 | June 1, 2018 | September 30, 2023 | DE VITO DABBS, ANNETTE J | reporter.nih.gov |
| Kidney transplant Preemptive therapy or Prophylaxis (KPoP) for CMV Preventionin D+R- Recipients | NIH | National Institute of Allergy and Infectious Diseases | 2024 | $510,927 | July 12, 2024 | September 30, 2024 | LIMAYE, ABHIJIT PRAKASH | reporter.nih.gov |
| Normothermic perfusion of steatotic livers for transplantation | NIH | National Institute of Diabetes and Digestive and Kidney Diseases | 2024 to 2025 | $509,200 | February 1, 2024 | December 31, 2026 | YEH, HEIDI | reporter.nih.gov |
| The genetically engineered pig heart as a bridge to allotransplantation in infants | NIH | National Heart, Lung, and Blood Institute | 2023 | $501,283 | April 1, 2023 | April 30, 2026 | CLEVELAND, DAVID C | reporter.nih.gov |
| Patient-Derived Kidney Organoids For Modeling Kidney Injury | NIH | National Institute of Diabetes and Digestive and Kidney Diseases | 2023 to 2025 | $499,488 | March 1, 2023 | February 28, 2026 | SUTHA, KEN | reporter.nih.gov |
| Innate allorecognition and KIR/LILR/HLA associations in kidney transplantation | NIH | National Institute of Allergy and Infectious Diseases | 2025 | $498,760 | August 22, 2025 | June 30, 2030 | LAKKIS, FADI G. | reporter.nih.gov |
| Intrinsic modulators of Treg lineage commitment and immunoregulation post-transplantation | NIH | National Institute of Allergy and Infectious Diseases | 2021 to 2022 | $498,000 | August 1, 2021 | July 31, 2024 | WEDEL, JOHANNES | reporter.nih.gov |
| Lung Allograft Stem Cell Regeneration and Immune Destruction | NIH | National Heart, Lung, and Blood Institute | 2024 to 2025 | $497,525 | June 14, 2024 | May 31, 2027 | LYNCH, THOMAS J | reporter.nih.gov |
Organizations
| Organization | Place | NIH awards | NIH amount | NSF awards | NSF amount |
|---|---|---|---|---|---|
| University of Pennsylvania | Philadelphia, PA | 45 | $75.8 million | 0 | $0 |
| Duke University | Durham, NC | 32 | $72.8 million | 0 | $0 |
| Johns Hopkins University | Baltimore, MD | 38 | $63.2 million | 0 | $0 |
| Massachusetts General Hospital | Boston, MA | 29 | $54.6 million | 0 | $0 |
| Columbia University Health Sciences | New York, NY | 23 | $49.5 million | 0 | $0 |
| Northwestern University at Chicago | Chicago, IL | 25 | $44.1 million | 0 | $0 |
| University of California, San Francisco | San Francisco, CA | 30 | $43.8 million | 0 | $0 |
| University of Pittsburgh at Pittsburgh | Pittsburgh, PA | 31 | $36.8 million | 0 | $0 |
| New York University School of Medicine | New York, NY | 28 | $30.1 million | 0 | $0 |
| Brigham and Women's Hospital | Boston, MA | 21 | $26.7 million | 0 | $0 |
| Vanderbilt University Medical Center | Nashville, TN | 15 | $25.6 million | 0 | $0 |
| Cleveland Clinic Lerner Com-Cwru | Cleveland, OH | 14 | $24.8 million | 0 | $0 |
| Stanford University | Stanford, CA | 22 | $23.5 million | 0 | $0 |
| Cedars-Sinai Medical Center | Los Angeles, CA | 4 | $21.3 million | 0 | $0 |
| Washington University | Saint Louis, MO | 20 | $20 million | 0 | $0 |
| Emory University | Atlanta, GA | 23 | $19.3 million | 0 | $0 |
| University of California Los Angeles | Los Angeles, CA | 14 | $19.2 million | 0 | $0 |
| University of Minnesota | Minneapolis, MN | 9 | $18.4 million | 0 | $0 |
| Icahn School of Medicine at Mount Sinai | New York, NY | 16 | $18.1 million | 0 | $0 |
| University of Washington | Seattle, WA | 11 | $18 million | 0 | $0 |
| Boston Children's Hospital | Boston, MA | 5 | $15.9 million | 0 | $0 |
| University of Colorado Denver | Aurora, CO | 11 | $13.7 million | 0 | $0 |
| Children's Hosp of Philadelphia | Philadelphia, PA | 8 | $13.5 million | 0 | $0 |
| University of Michigan at Ann Arbor | Ann Arbor, MI | 12 | $12.6 million | 0 | $0 |
| Mayo Clinic Rochester | Rochester, MN | 14 | $11.4 million | 0 | $0 |
| University of Florida | Gainesville, FL | 10 | $11.1 million | 0 | $0 |
| Yale University | New Haven, CT | 16 | $10.4 million | 0 | $0 |
| University of Maryland Baltimore | Baltimore, MD | 9 | $10 million | 0 | $0 |
| University of Wisconsin-Madison | Madison, WI | 8 | $9.9 million | 0 | $0 |
| University of Alabama at Birmingham | Birmingham, AL | 10 | $9.7 million | 0 | $0 |
| University of Chicago | Chicago, IL | 7 | $9.3 million | 0 | $0 |
| Ohio State University | Columbus, OH | 7 | $7.4 million | 0 | $0 |
| Wake Forest University Health Sciences | Winston-Salem, NC | 3 | $7.2 million | 0 | $0 |
| Methodist Hospital Research Institute | Houston, TX | 8 | $6.9 million | 0 | $0 |
| Sylvatica Biotech, Inc. | North Charleston, SC | 4 | $6.8 million | 0 | $0 |
| Pharmain Corporation | Bothell, WA | 1 | $6.8 million | 0 | $0 |
| Bivacor, Inc. | Houston, TX | 3 | $6.5 million | 0 | $0 |
| Weill Medical Coll of Cornell Univ | New York, NY | 7 | $6.1 million | 0 | $0 |
| University of Miami School of Medicine | Coral Gables, FL | 4 | $5.9 million | 0 | $0 |
| University of Southern California | Los Angeles, CA | 4 | $5.6 million | 0 | $0 |
| University of Virginia | Charlottesville, VA | 3 | $5.3 million | 0 | $0 |
| Hennepin Healthcare Research Institute | Minneapolis, MN | 7 | $5.2 million | 0 | $0 |
| Temple Univ of the Commonwealth | Philadelphia, PA | 5 | $5.1 million | 0 | $0 |
| Indiana University Indianapolis | Indianapolis, IN | 7 | $5.1 million | 0 | $0 |
| Medical University of South Carolina | Charleston, SC | 7 | $4.8 million | 0 | $0 |
| SUNY at Buffalo | Amherst, NY | 3 | $4.8 million | 0 | $0 |
| Rutgers Biomedical and Health Sciences | Newark, NJ | 6 | $4.7 million | 0 | $0 |
| University of California-Irvine | Irvine, CA | 4 | $4.5 million | 0 | $0 |
| Expanse Bio LLC | North Charleston, SC | 2 | $4.4 million | 0 | $0 |
| Evrys Bio, LLC | Doylestown, PA | 1 | $4 million | 0 | $0 |
| Arkansas Children's Hospital Res Inst | Little Rock, AR | 1 | $3.9 million | 0 | $0 |
| University of Texas HLTH Sci CTR Houston | Houston, TX | 3 | $3.8 million | 0 | $0 |
| Palo Alto Veterans Instit for Research | Palo Alto, CA | 3 | $3.7 million | 0 | $0 |
| Nour Heart, Inc. | Vienna, VA | 1 | $3.6 million | 0 | $0 |
| Arizona State University | Scottsdale, AZ | 3 | $3.6 million | 0 | $0 |
| Biomedinnovations, Inc. | Denver, NC | 1 | $3.5 million | 0 | $0 |
| University of California, San Diego | La Jolla, CA | 5 | $3.4 million | 0 | $0 |
| Case Western Reserve University | Cleveland, OH | 3 | $3.4 million | 0 | $0 |
| Ut Southwestern Medical Center | Dallas, TX | 4 | $3.4 million | 0 | $0 |
| Univ of North Carolina Chapel Hill | Chapel Hill, NC | 3 | $3 million | 0 | $0 |
| Tufts University Boston | Boston, MA | 3 | $2.8 million | 0 | $0 |
| Georgia State University | Atlanta, GA | 1 | $2.8 million | 0 | $0 |
| Affinergy, LLC | Durham, NC | 3 | $2.8 million | 0 | $0 |
| University Health Network | Toronto | 2 | $2.8 million | 0 | $0 |
| Cornell University | Ithaca, NY | 1 | $2.7 million | 0 | $0 |
| Glycan Therapeutics Corporation | Raleigh, NC | 2 | $2.7 million | 0 | $0 |
| University of Iowa | Iowa City, IA | 2 | $2.6 million | 0 | $0 |
| University of South Florida | Tampa, FL | 2 | $2.6 million | 0 | $0 |
| Brown University | Providence, RI | 1 | $2.6 million | 0 | $0 |
| Pennsylvania State Univ University Park | University Park, PA | 2 | $2.5 million | 0 | $0 |
| University of Massachusetts Amherst | Amherst, MA | 1 | $2.5 million | 0 | $0 |
| Emocha Mobile Health, Inc. | Owings Mills, MD | 2 | $2.4 million | 0 | $0 |
| Univ of Arkansas for Med Scis | Little Rock, AR | 1 | $2.4 million | 0 | $0 |
| University of New Mexico Health Scis CTR | Albuquerque, NM | 1 | $2.4 million | 0 | $0 |
| University of Utah | Salt Lake City, UT | 4 | $2.3 million | 0 | $0 |
| WR Biotech, LLC | Tampa, FL | 3 | $2.1 million | 0 | $0 |
| Baylor College of Medicine | Houston, TX | 5 | $2.1 million | 0 | $0 |
| Texas Heart Institute | Houston, TX | 1 | $2.1 million | 0 | $0 |
| Auritec Pharmaceuticals, Inc. | Pasadena, CA | 1 | $2 million | 0 | $0 |
| University of Kentucky | Lexington, KY | 1 | $2 million | 0 | $0 |
| X-Therma Inc. | Hercules, CA | 1 | $2 million | 0 | $0 |
| University of Illinois at Chicago | Chicago, IL | 2 | $2 million | 0 | $0 |
| Xequel Bio, Inc. | Mount Pleasant, SC | 1 | $2 million | 0 | $0 |
| Hastings Center, Inc. | Garrison, NY | 1 | $1.9 million | 0 | $0 |
| Vanderbilt University | Nashville, TN | 1 | $1.7 million | 0 | $0 |
| Terasaki Institute for Biomedical Innovation | Woodland Hills, CA | 2 | $1.7 million | 0 | $0 |
| ST. Joseph's Hospital and Medical Center | Phoenix, AZ | 1 | $1.6 million | 0 | $0 |
| Inova Health Care Services | Fairfax, VA | 2 | $1.5 million | 0 | $0 |
| Lurie Children's Hospital of Chicago | Chicago, IL | 1 | $1.5 million | 0 | $0 |
| Children's Research Institute | Washington, DC | 1 | $1.5 million | 0 | $0 |
| Xylyx Bio, Inc. | Brooklyn, NY | 1 | $1.5 million | 0 | $0 |
| Rho Federal Systems Division, Inc. | Durham, NC | 1 | $1.5 million | 0 | $0 |
| Cryocrate, LLC | Columbia, MO | 1 | $1.5 million | 0 | $0 |
| North Carolina State University | Raleigh, NC | 1 | $1.5 million | 0 | $0 |
| Cincinnati Childrens Hosp Med CTR | Cincinnati, OH | 2 | $1.4 million | 0 | $0 |
| Tissue Testing Technologies, LLC | North Charleston, SC | 3 | $1.3 million | 0 | $0 |
| Informai, Inc. | Houston, TX | 1 | $1.3 million | 0 | $0 |
| University of Kansas Medical Center | Kansas City, KS | 3 | $1.2 million | 0 | $0 |
| Georgetown University | Washington, DC | 3 | $1.1 million | 0 | $0 |
| New England Research Institutes, Inc. | Wilmington, DE | 1 | $1.1 million | 0 | $0 |
Funding by fiscal year
| Fiscal year | NIH awards | NIH amount | NSF awards | NSF amount |
|---|---|---|---|---|
| 2025 | 405 | $264,734,655 | 0 | $0 |
| 2024 | 392 | $224,269,957 | 0 | $0 |
| 2023 | 387 | $217,638,897 | 0 | $0 |
| 2022 | 362 | $190,485,874 | 0 | $0 |
| 2021 | 351 | $185,979,864 | 0 | $0 |
Open federal funding opportunities
From Grants.gov: notices that funded awards in this table, and open notices on the same agency and assistance listing.
| Open opportunity | Number | Agency | Listing | Closes | Award ceiling | Why it matches |
|---|---|---|---|---|---|---|
| Change of Recipient Organization (Type 7 Parent Clinical Trial Optional) | PA-24-254 | NIH | July 12, 2027 | Not listed | Notice number printed on 11 awards here | |
| Mentored Clinical Scientist Research Career Development Award (Parent K08 Independent Clinical Trial Not Allowed) | PA-24-182 | NIH | May 8, 2027 | Not listed | Notice number printed on 3 awards here | |
| Mentored Patient-Oriented Research Career Development Award (Parent K23 Independent Clinical Trial Not Allowed) | PA-24-185 | NIH | May 7, 2027 | Not listed | Notice number printed on 2 awards here | |
| Mentored Research Scientist Development Award (Parent K01 - Independent Clinical Trial Required) | PA-24-175 | NIH | May 7, 2027 | Not listed | Notice number printed on 1 award here | |
| Infectious Diseases Clinical Trials Network (IDCTN) (UM1 Clinical Trial Required) | RFA-AI-27-002 | NIH | 93.855 | November 10, 2026 | Not listed | Same assistance listing 93.855 as 277 awards here |
| Clinical Research Network on Antimicrobial Resistance (UM1 Clinical Trial Required) | RFA-AI-27-005 | NIH | 93.855 | November 10, 2026 | Not listed | Same assistance listing 93.855 as 277 awards here |
| Ethical, Legal and Social Implications (ELSI) Small Research Grant (R03 Clinical Trial Optional) | PAR-25-370 | NIH | 93.855 | November 16, 2026 | $50,000 | Same assistance listing 93.855 as 277 awards here |
| Ethical, Legal and Social Implications (ELSI) Exploratory/Developmental Research Grant (R21 Clinical Trial Optional) | PAR-25-369 | NIH | 93.855 | November 18, 2026 | Not listed | Same assistance listing 93.855 as 277 awards here |
| Ethical, Legal and Social Implications (ELSI) Research (R01 Clinical Trial Optional) | PAR-25-371 | NIH | 93.855 | November 18, 2026 | Not listed | Same assistance listing 93.855 as 277 awards here |
| Intervention Research to Improve Native American Health (R01 Clinical Trial Optional) | PAR-25-379 | NIH | 93.855 | January 7, 2027 | Not listed | Same assistance listing 93.855 as 277 awards here |
| HIV/AIDS Clinical Trials Network Leadership and Operations Centers | RFA-AI-28-001 | NIH | 93.855 | January 22, 2027 | Not listed | Same assistance listing 93.855 as 277 awards here |
| HIV/AIDS Clinical Trials Network Laboratory Centers | RFA-AI-28-002 | NIH | 93.855 | January 22, 2027 | Not listed | Same assistance listing 93.855 as 277 awards here |
| HIV/AIDS Clinical Trials Network Statistical and Data Management Centers | RFA-AI-28-003 | NIH | 93.855 | January 22, 2027 | Not listed | Same assistance listing 93.855 as 277 awards here |
| HIV/AIDS Clinical Trials Network Clinical Trials Units | RFA-AI-28-004 | NIH | 93.855 | January 22, 2027 | Not listed | Same assistance listing 93.855 as 277 awards here |
| Precision and Systems Biology to Uncover the Link Between Chronic and Infectious Diseases | RFA-AI-28-014 | NIH | 93.855 | January 22, 2027 | Not listed | Same assistance listing 93.855 as 277 awards here |
| Immune Tolerance Network (UM1 Clinical Trial Required) | RFA-AI-28-005 | NIH | 93.855 | January 29, 2027 | Not listed | Same assistance listing 93.855 as 277 awards here |
| Translational Centers Using Microphysiological Systems for Infectious Diseases (U54 Clinical Trial Not Allowed) | RFA-AI-28-012 | NIH | 93.855 | January 29, 2027 | Not listed | Same assistance listing 93.855 as 277 awards here |
| Accelerating Research and Development of Next Generation Vaccines against Malaria - a Model for Mosquito-Borne Diseases (R61/R33 Clinical Trial Not Allowed) | RFA-AI-28-024 | NIH | 93.855 | February 11, 2027 | Not listed | Same assistance listing 93.855 as 277 awards here |
| NLM Institutional Grants for Research Training in Biomedical Informatics, Data Science, and AI (T15 Independent Clinical Trial Not Allowed) | RFA-LM-28-001 | NIH | 93.855 | February 11, 2027 | $775,000 | Same assistance listing 93.855 as 277 awards here |
| NIH, CDC and FDA Small Business Innovation Research Grant (Parent SBIR [R43/R44] Clinical Trial Optional) | PA-27-100 | NIH | 93.855 | April 5, 2027 | Not listed | Same assistance listing 93.855 as 277 awards here |
Updated November 3, 2026. Read from NIH RePORTER ExPORTER and NSF Award Search. Published by NIH and NSF as U.S. government data. NIH awards are fiscal years 2021 to 2025 (NIH files published to 2026-07-09); NSF awards are fiscal years 2022 to 2026 (NSF files published to 2026-11-02). NIH amounts are the total cost of each fiscal year in the window; NSF amounts are the funds obligated in the window. Organizations are matched on the UEI. Open opportunities come from Grants.gov and match on agency and assistance listing number, and on the notice number NIH prints on an award. Free to reuse with credit to SpecStream under CC BY 4.0. Spot a wrong value? Write to [email protected] with the link to this page.